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ABSTRACT 
Model Studies for Molybdenum Enzymes •. The Reduction of 
Cytochrome c By Molybdenum('.V)-Cysteine Complexes 
by 
Glen D. Lawrence, Doctor of Philosophy 
Utah State University, 1976 
Major Professor: Dr. Jack T. Spence 
Department: Chemistry and Biochemistry 
xi 
.( III) ll The reduction of ferricytochrome c cyt _c . , as we as some iron 
ligand complexes and chemically modified derivatives of cyt cIII, by 
two molybdenum(V)-cysteine complexes has been investigated as a model 
for electron transfer in molybdenum enzymes. III The reduction of cyt c 
by di-µ-oxo-bis[oxo(L-cysteinato)molybdate(V)] (I) is first order in 
III 
cyt c and zero order in I over a wide range in concentration of I at 
neutral pH. III The reduction of cyt c by µ-oxo-bisfoxodihydroxo(L-
cysteinato)molybdate(V)J (II) is first order in both reactants and has 
a rate several orders of magnitude greater than the rate of reduction 
by I. Activation parameters have been determined for both reactions. 
III The reduction of two pyridoxal phosphate derivatives of cyt c 
by I proceeds at the same rate as the reduction of native cyt c 11 I, 
while the mononitromonotyrosyl derivative is reduced somewhat faster. 
III The reduction of the N-formyltryptophyl derivative of cyt c by I is 
biphasic, with the fast phase proceeding with a rate similar to the 
xii 
III 
native cyt c and the slow phase being somewhat slower. The reduction 
III by I of all derivatives studied is first order in cyt c and zero 
order in I, suggesting the mechanism does not change with these chemi-
cally modified forms of cyt cIII. 
The pyridoxal phosphate and mononitromonotyrosyl derivatives of 
III cIII and cyt c are reduced by II with rates similar to the native cyt 
by the same mechanism. The reduction of the N-formyltryptophyl deriva-
tive by II has complicated kinetics which suggest the presence of at 
III least two formyl-cyt c species. 
The reduction of the cyanide, azide and imidazole complexes of 
III 
cyt c by II occurs at a greatly reduced rate and by a different 
III mechanism than the reduction of native cyt c The rate of reduction 
of the cyanide and azide complexes is dependent on the rate of dissoci-
ation of the ligand cyt cIII complex and independent of the concentration 
of II. The reduction of the imidazole complex by II is much more com-
plicated, with the rate independent of II at very low concentrations but 
shows a dependence on the concentration of II at higher concentrations. 
Rate constants have been determined for the reactions and possible 
mechanisms have been developed. The results have been discussed with 
regard to electron transfer in molybdenum enzymes and electron transfer 
III to cyt c This study is especially valuable as a model for the 
hepatic sulfite oxidase enzyme. 
(185 pages) 
INTRODUCTION 
Transition metal ions play a very important role in biological 
oxidation-reduction reactions. Many of the elements of the first tran-
sition series have been shown to be involved in biochemical systems. 
Molybdenum is unique among the elements of the second and third tran-
sition series, however, in being essential in several enzymatic systems. 
Two molybdenum enzymes which are ultimately important to all living 
organisms are nitrogenase and nitrate reductase (1), which are involved 
in reducing inorganic nitrogen so it may be incorporated into amino 
acides, nucleic acids and other nitrogenous cell constituents. Other 
enzymatic systems which contain molybdenum include xanthine oxidase, 
xanthine dehydrogenase, aldehyde oxidase, sulfite oxidase and formate 
dehydrogenase (1,2). All of these molybdenum enzymes also contain iron, 
either as heme or in iron-sulfur clusters, and some contain additional 
prosthetic groups such as flavin and possibly quinone (1,2). 
Iron is rather ubiquitous in nature and is probably the most 
studied transition metal with respect to its function in biological 
systems. Iron exists predominantly in two general forms when it is 
involved in the catalysis of biological electron transfers: in the 
heme prosthetic group or in iron-sulfur proteins. Proteins containing 
the heme group, which are involved in electron transfer reactions, are 
called cytochromes. The most extensively studied of the cytochromes is 
cytochrome c, the X-ray crystal structure having been determined for 
oxidized horse heart cytochrome c (3) and reduced tuna heart cytochrome 
C (4). 
2 
Enzymes which have been shown to contain both molybdenum and a 
heme moiety include nitrate reductase from Neurospora crassa (S) and 
Escherichia coli (6), hepatic sulfite oxidase (7) and formate dehydro-
genase (2). Knowledge of the ligand environment of molybdenum in 
enzymatic systems is limited, at best. Some evidence for sulfur coordin-
ation in xanthine oxidase has been obtained from comparison of electron 
spin resonance parameters of the enzyme with those of molybdenum com-
plexes containing sulfur ligands (1,8). 
The purpose of this study is to gain a better understanding of the 
roles of molybdenum and the heme moiety in biological electron trans-
fers, as well as a better understanding of their interactions with each 
other. Molybdenum(V)-cysteine complexes were used in this study as a 
model for the molybdenum moiety in proteins. The reduction of horse 
heart cytochrome c by these Mo(V)-cysteine complexes has been investi-
gated as a model for electron transfer in the molybdenum-heme enzyme 
systems. 
It is obvious that the results of such a study are not only valuable 
for the development of a model for molybdenum-heme iron interactions, but 
may also provide some insight into the mechanism of electron transfer in 
cytochrome c. For that reason, modified cytochrome c species were also 
used in this study as an approach to elucidating sites within the mole-
cule which are important in the electrom transfer process. 
LITERATURE REVIEW 
General Survey of Molybdenum in Biochemical Systems 
The importance of molybdenum in biological systems has been known 
for some time. Bortels (9) first demonstrated a molybdenum requirement 
3 
in Azotobacter chroococcum in 1930. Burk (10) later showed that molyb-
denum was a specific requirement for nitrogen fixation in several species 
of Azotobacter. Molybdenum has since been shown to be an essential con-
stituent of several enzymes from a wide variety of organisms. These 
enzymes include nitrogenase, nitrate reductase and formate dehydrogenase 
from plants and microorganisms and xanthine oxidase, aldehyde oxidase, 
sulfite oxidase and xanthine dehydrogenase generally isolated from ani-
mal tissue (several of the latter enzymes are also found in plants and 
microorganisms) (1,2,8). In addition to molybdenum, all of these en-
zymes contain iron, either as heme iron or an iron-sulfur moiety, and 
some also contain flavin. The enzyme formate dehydrogenase has been 
shown to contain selenium as a cofactor (2). 
The oxidation state of molybdenum in enzymes is generally accepted 
to be 6+ and 5+, probably alternating between these two states during 
the catalytic cycle. The possibility of lower oxidation states cannot, 
however, be ruled out. Because Mo(V) is a d 1 ion, it is especially 
amenable to studies by electron spin resonance spectroscopy (esr), and, 
in fact, that has been the most extensively used tool in studying 
molybdenum enzymes. The Mo(V) esr signal is observed in several 
enzymes upon the addition of reducing substrate, which suggests the 
metal is in the 6+ oxidation state in the resting enzyme. The possi-
bility of the addition of substrate causing spin decoupling of Mo(V) 
in the resting enzyme cannot, however, be ignored (11). Xanthine 
dehydrogenase from Micrococcus lactilyticus exhibits a large Mo(V) esr 
signal in the resting enzyme which changes and decreases slightly upon 
addition of reducing substrate, suggesting the molybdenum may remain 
as Mo(V) throughout the catalytic cycle (12). 
Although the Mo(III) ion is paramagnetic, its esr signal has never 
been observed in biochemical systems. This does not, however, indicate 
that it is not present in these systems since its being a d 3ion would 
cause considerable line broadening in the esr spectrum, making it un-
detectable in the concentrations of enzyme which are normally studied 
(13). Furthermore, arguments concerning the reduction potential of the 
Mo(V)/Mo(III) couple, estimated to be about -0.6 to -1.0 at neutral pH 
(14), are not conclusive since the potential is strongly dependent on 
the ligands (13). Some relatively stable complexes of Mo(IV) are known, 
but are generally considered unlikely to be present in biological sys-
tems (13). 
The ligand environment of molybdenum in these enzymes is, at best 
poorly defined. Some work involving inhibition studies with sulfhydryl 
binding agents has implicated cysteine as a _ligand (15). Further evi-
dence for sulfur ligands has come from ear data for xanthine oxidase 
( 8) : high g values and low molybdenum hyperfine couplings in signals av 
from the enzyme are analogous to those in Mo(V)-thiol comple~es. 
4 
5 
Model Complexes for Molybdenum Enzymes 
Much attention has been concentrated on cysteine as a ligand for 
molybdenum in model systems of molybdenum enzymes. Complexes of Mo(V) 
and Mo(VI) with L-cysteine and related ligands have been prepared (16). 
The X-ray crystal structure for the dioxobridged Mo(V)-cysteine dimer 
(di-µ-oxo-bis[oxo(L-cysteinato)molybdate(V)]) (I) has been determined 
(17). The Mo atoms in the dianion are in a distorted octahedral environ-
ment with cysteine acting as a tridentate ligand: 
The bond length of the carboxyl oxygen-molybdenum bond is very long, 
however, and the bond is thought to be displaced in solution by solvent 
molecules (17). Spence and Chang (18) found that Mo(VI) forms com-
plexes with cysteine with Mo:cysteine ratios of 1:1 to 1:3 in the pH 
range 4 to 6.5; however, there is no detectable complex formation at 
higher pH. 
Since it has been suggested that cysteine may be a ligand for 
molybdenum in enzymes and the binuclear dioxobridged Mo(V)-cysteine 
complex (I) has been well characterized, this complex has been the 
subject of some very extensive investigation as a model system. The 
complex is diamagnetic and exhibits an intense absorption band at 306 
nm with a molar extinction of 12,500 (19). A solution of the complex 
6 
is converted from a yellow color to blue upon standing at pH 8-11 and 
a weak esr signal and weak absorption band near 600 nm are observed. 
Both the esr signal and the visible absorption were initially attributed 
to a small amount of paramagnetic monomer in equilibrium with the dimer 
under alkaline conditions (20). Further investigation of this system 
indicated that in the presence of excess cysteine at pH> 9.0 the absorp-
tion band at 306 nm completely disappears, although the esr signal still 
accounts for less than 1 percent of the total molybdenum (19). The weak 
absorption band near 600 run(£= 100) is therefore due to another species 
which is believed to be the monoxobridged dimer (µ-oxo-bis[oxodihydroxo-
(L-cysteinato)molybdate(V)]) (II). 
When the dibridged complex is allowed to stand under alkaline con-
ditions without excess cysteine added, the monoxobridged cysteine com-
plex disappears yielding another species with broad absorption maxima 
near 575 and 750 run (21), the intensity of the absorption bands being 
pH dependent. It was found that cysteine is released from the complex 
during the formation of this latter species, suggesting that this 
species is a monoxobridged dimer with the cysteine ligands hydrolyzed. 
The following scheme was proposed (19): 
7 
OH- 0 0 co-,( s......_ I / o'--... I ,,...N) 2 I 111( Mo Mo 
f\O -~c N/6~ H66~S 
n 
4X ~ t,,A ,-l.---X ]I +2cysteine 111( 
x/l 'o-1 HCf I 'x OH OH 
nr 
where X =OH, H20 or buffer ions. 
Further studies showed that complex II readily reduces flavin 
mononucleotide (22). In the course of the reaction large intermediate 
esr signals were observed which were attributed to both flavosemiquinone 
and Mo(V) monomer. This strongly suggested that the initial fast re-
action involved a one electron transfer from complex II to FMN. This 
system serves as an interesting model for xanthine oxidase, since the 
proposed scheme for electron transfer in that enzyme involves the trans-
fer of electrons from reducing substrate through molybdenum to flavin 







Molybdenum Cofactors in Enzymes 
Nason and coworkers (23-25) have obtained interesting results con-
cerning subunit relationships in nitrate reductase from Neurospora 
crassa which may have important implications for all molybdenum contain-
ing enzymes. An active assimilatory nitrate reductase can be formed in 
vitro by incubation of extracts of a nitrate-induced N. crassa mutant, 
nit-1 (which lacks nitrate reductase activity), with other acid-treated 
enzymes known to contain molybdenum. The implication is that a low 
molecular weight molybdenum containing subunit, common to all molybdenum 
enzymes, is responsible for imparting nitrate reductase activity in the 
mutant extract. 
Cell free extracts of a selected group of bacteria, capable of 
metabolizing dinitrogen and/or nitrate, were found to contain a soluble 
form of constitutive component which is active in the in vitro formation 
of NADPH-nitrate reductase activity when mixed with extracts of the N. 
crassa nit-1 mutant (26). This constitutive component was dialyzable 
and postulated to be a low molecular weight cofactor or polypeptide 
presumed to contain molybdenum. Several other reports have appeared in 
the literature which lend support to such a low molecular weight molyb-
denum subunit common to molybdenum enzymes (27-31). 
Ganelin et al. (28) isolated a molybdenum containing peptide from 
the molybdoferredoxin component of the nitrogenase enzyme from Azoto-
bacter vinelandii. About 50% of the molybdenum in this molybdoferredoxin 
component was removed from the protein by high ionic strength in the 
form of a low molecular weight ('vlQOO) peptide complex, the other 50% of 
the molybdenum remained tightly bound to the protein but could, however, 
9 
be removed under alkaline conditions. The isolated Mo-peptide complex 
exhibited an esr signal at approximately g = 2.00 and was tentatively 
attributed to an Mo(V) complex. The esr signal disappeared upon reduc-
tion with dithionite, presumably due to reduction of Mo(V) to a lower 
oxidation state. Zumft (31) isolated several low molecular weight 
components from acid-treated molybdoferredoxin from Clostridium pasteur-
ianum nitrogenase, one of which had a molecular weight of less than 1300 
and contained molybdenum. This molybdenum component has an absorption 
spectrum with narrow bands at 311 and 394 nm and was able to restore 
nitrate reductase activity to extracts of N. crassa mutant, nit-1. 
Nitrate Reductase 
Several studies, mostly utilizing esr techniques, have revealed the 
components of nitrate reductase systems from various sources. Garrett 
and Nason (32, 33) have shown that assimilatory nitrate reductase from 
N. crassa contains ab-type cytochrome, cyt b
557
, which shows the same 
flavin requirement as NADPH-nitrate reductase activity and its reduction 
is insens _i ti ve to cyanide, al though cyanide blocks its reoxidation by 
nitrate. Kinsky and McElroy (34) showed the NADPH-cytochrome c reductase 
and NADPH-nitrate reductase could be induced concomitantly by nitrate. 
These activities have so far proved inseparable. Garrett and Nason (33) 
proposed the following electron transfer scheme for the Neurospora 
enzyme: 




NADPH --> FAD / 
~ cyt C 
10 
The NADPH-cytochrome c reductase activity is inhibited by .Q_-phenanthro-
line and 8-hydroxyquinoline but not by azide, cyanide or thiourea. The 
NADPH-nitrate reductase activity is inhibited by all of these reagents. 
FADH and reduced methylviologen can replace NADPH as electron donors to 
give nitrate reductase activities. The FADH- and reduced methylviologen-
nitrate reductase activities are inhibited by cyanide, azide and 
thiourea but not by the chelating ligands. It was suggested that the cyt 
b 557 would not likely be influenced by metal binding agents, such as 
.2.-phenanthroline and 8-hydroxyquinoline, and therefore another metal must 
be present to account for such observations. The identification of this 
metal has not yet been reported. 
Several anaerobic organisms synthesize dissimilatory (or respir-
atory) nitrate reductase which utilizes nitrate as a terminal electron 
acceptor for metabolic processes. The enzyme from Pseudomonas aeruginosa 
was shown to contain cytochrome c (34,35). The proposed electron trans-
fer scheme for this enzyme is (36): 
NADPH +FAD+ cyt c +Mo+ N0
3 
A study of the dissimilatory nitrate reductase from Micrococcus denit-
rificans revealed the presence of molybdenum and non-heme iron (iron and 
acid labile sulfide) in this enzyme, but it did not contain heme or 
flavin (36). It is obvious that nitrate reductases can be obtained from 
diverse sources with widely varying properties, all containing molyb-




Sulfite oxidase has been isolated in a high state of purity from 
mammalian (7,37,38) and avian (38) liver. Its role appears to be the 
oxidative detoxification of sulfur compounds in mammals, especially the 
oxidation of sulfur dioxide and sulfite to sulfate. The importance of 
sulfite oxidase in humans was demonstrated in a report of a child whose 
liver, kidney and brain were completely deficient in this enzyme (39). 
Large amounts of cysteine-S~sulfate, sulfite and thiosulfate, but not 
sulfate, were observed in the child's urine. The patient died at 2.5 
years with severe neurological disorders and other abnormalities. 
Cysteine-S-sulfate, like glutamate and similar acidic amino acids have 
been shown to have both neuroexcitatory and neurotoxic properties, 
causing rapid destruction of neurons in the retina and hypothalamus (40). 
The presence of molybdenum in bovine hepatic sulfite oxidase was 
discovered, more or less by accident, in esr experiments designed to 
study the heme prosthetic group (41). Sulfite oxidase from various 
other sources, including chicken liver, human liver, wheat germ and 
Thiobacillus thioparus, has been shown to contain molybdenum by esr 
investigation (38). A Mo(V) ear signal is observed in the enzyme from 
all the above mentioned sources upon addition of sulfite. The mammalian 
enzyme contains ab-type cytochrome component which is reduced in the 
steady state (in the presence of sulfite and oxygen), but oxidized if 
ferricyanide replaces oxygen as electron acceptor (42). Cytochrome c 
could also function as electron acceptor, presumably at the same site as 
12 
ferricyanide, since it is also reduced more rapidly than cyt b of the 
enzyme. Furthermore, the reduction of ferricyanide and cytochrome c 
was inhibited by anions, whereas the reduction of oxygen was not, 
indicating the active sites for these two classes of electron acceptor 









Hepatic sulfite oxidase, from both avian and manunalian sources, has 
a molecular weight of about 110,000 and has two similar, if not identi-
cal, subunits (7,38). The enzyme contains two molybdenum and two heme 
per molecule, further suggesting identical subunits. Kinetic studies, 
however, showed that half of the heme is reduced very rapidly upon ad-
dition of sulfite and the other half reduced more slowly (42). These 
results were interpreted to mean the two subunits possessed different 
kinetic behavior, probably due to conformational differences. 
Formate Dehydrogenase 
Formate dehydrogenase has recently been purified from Escherichia 
coli and found to contain molybdenum, heme, selenium and non-heme iron 
in the relative proportions of 1:1:1:14 (2). The enzyme has a molecular 
weight of approximately 590,000 with 3 different polypeptide subunits. 
The heme content corresponds to an equivalent weight of 154,000, 
suggesting a tetrameric structure. The absorbance spectrum of the 
enzyme indicates the presence of ab-type cytochrome which can be 
completely reduced by formate. 
13 
Kinetic studies have not been reported on this enzyme to determine 
the sequence of intromolecular electron transfer or involvement of the 
prosthetic groups. A proposed function for formate dehydrogenase in 
E . ..£2!.! is that it is involved in electron transfer from formate to 
nitrate and is probably linked to nitrate reductase via a membrane elec-
tron carrier (e.g. quinone) (2). 
Structure and Physical Properties of Cytochrome c 
Cytochrome c is a small electron transfer protein found in mito-
chondria of all aerobic organisms. It is part of the terminal respira-
tory electron transport chain, which completes the breakdown of foods 
to carbon dioxide and water and couples the energy liberated to phos-
phorylation of ADP. It is a soluble hemoprotein made up of one heme 
group and a single polypeptide chain, whereas the other cytochrome 
components of the chain are part of multimolecular lipoprotein complexes. 
The iron atom of the heme group alternates between the 2+ and 3+ oxi-
dation states as cytochrome c interacts with cytochrome c reductase 
and cytochrome c oxidase. An extensive review of structure and func-
tion in cytochrome c has been presented by Margoliash and Schejter (43). 
The unusual stability and ease of isolation of cytochrome c has 
resulted in the accumulation of a vast amount of information on 
structure and reactivity of this protein since it was first isolated 
from baker's yeast by Keilin in 1930 (44). The primary structures of 
cytochrome c from over 30 species are known, covering a spectrum of 
orgamisms from mammals to yeast and fungi (45). Dickerson (46) has 
recently discussed similarities in the structure of cytochrome c from 
many eucaryotic organisms and the curious invariance of the primary 
sequence. Since horse heart cytochrome c is commercially available, 
14 
and the majority of investigations, including this one, use this source, 
this survey will be concerned primarily with this protein. 
Horse heart cytochrome c contains 104 amino acid residues, with the 
N-terminal glycine residue acetylated. The amino acid sequence is 
shown in Figure 1. The heme group is covalently bound to the orotein 
by thioether linkages to cysteinyl residues 14 and 17. The silver salt 
method of thioether bond cleavage has allowed the unequivocal identifi-
cation of the linkage of the protoheme through the a-carbon of the 
vinyl side chains to the sulfur of the cysteinyl residues (47). Four 
of the octahedral ligands of the iron are contributed by the porphyrin 
ring and the fifth and sixth coordination sites are occupied by the 
imidazole nitrogen of histidine-18 and the sulfur of methionine-BO (3). 
Such a closed structure for the heme environment makes the iron rela-
tively inaccessible to iron binding ligands, in comparison with the iron 
of hemoglobin and myoglobin. 
The X-ray crystal structures of oxidized cytochrome c from horse and 


















Figure 1. The amino acid sequence of horse heart cytochrome c. 
[CYS] are the cysteine residues involved in the thioether 
linkage to the porphyrin side chains. (*) denotes the 
residues which provide the fifth and sixth ligands to 
the heme iron. Amino acid residues which are invariant 
in all species studied are shown by capital letters. 
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Figure 2 shows the structure of oxidized horse heart cytochrome c as 
determined by X-ray crystallography by Dickerson and coworkers (3). This 
figure has been color coded for clarity. Notice that the hydrophilic 
amino acids are located on the exterior of the protein in contact with 
the polar environment and the interior of the protein is very hydro-
phobic. 
One of the more peculiar characteristics of the i:rotein is its high 
lysine content; the horse protein contains 19 lysine residues (45). It 
also has 2 arginines and only 12 acidic residues. This results in a 
basic protein with an isoelectric point near pH 10 (48). It is of 
interest that both arginine and 5 of the lysine residues are totally 
invariant in all cytochromes c studied (.46). Note in Figure 2 that most 
of the lysine residues form clusters on the surface of the protein (e.g. 
lysyl residues 86-88 form a cluster in the upper left portion of the 
protein and residues 5, 7, and 8 form another cluster in the upper right 
portion). Wada and 0kunuki (49) have shown that trinitrophenylation 
of lysine-13, located at the outer edge of the heme crevice, causes a 
large decrease in the reactivity of the protein with cytochrome c oxi-
dase. Trinitrophenylation of other lysine residues has a much smaller 
effect. Acetylation of lysine residues also inhibits oxidase activity, 
with activity decreasing linearly with the number of lysyl residues 
acetylated (50). 
Another feature of the molecule worthy of note is the hydrophobic 
nature of the left heme crevice. Tyrosine residues 67 and 74 and 
tryptophan-59 have been suggested to be involved in electron transfer 
Figure 2. The structure of oxidized horse heart cytochrome c as 
determined by X-ray crystallography by Dickerson and 
coworkers (reproduced from reference 46). Alpha-carbon 
atoms are numbered anrl the amide groups connecting the 
alpha carbons are represented by a solid line. Three 
side : chains have been omitted for clarity: leucine-35, 
phenylalanine-36 and leucine-98. The heme edge toward 
the viewer is exposed to the environment. 
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to cytochrome c (51). Such electron transfer has been proposed to pro-
ceed via TT-electron cloud interactions of these residues with one 
another and with the porphyrin ring. 
Comparison of the structures of oxidized and reduced proteins indi-
cates that the peptide chain from residues 80 to 83 swings to the right 
upon reduction (refer to Figure 2), and phenylalanine-82 becomes tucked 
into the heme crevice nearly parallel to the heme plane (46). This con-
formational change presumably displaces an anion from the heme crevice, 
which has been proposed to stabilize the Fe(III) charge, and the anion 
in turn is stabilized by lysine-13 (52). The result is a much more com-
pact and stable protein in the reduced state (4). A recent nmr study 
has shown that the aromatic residues do undergo changes in orientation 
and interactions with other aromatic residues in the course of oxidation 
and reduction in solution (53). 
In general, speculation has favored two separate paths for the elec-
tron in the reactions with the oxidase and reductase enzymes. A puri-
fied, single-site antibody for cytochrome c, prepared in rabbit, blocked 
reaction of human cytochrome c with cytochrome c oxidase without affect-
ing its activity with cytochrome c reductase (54). Other modifications 
have resulted in specific inhibition of either oxidase or reductase 
activities (vide infra). The cytochrome c oxidase has been proposed to 
interact at the top of the molecule (as shown in Figure 2), binding 
through the lysyl residues, while the reductase has been proposed to 
interact either in the vicinity of tyrosine-74 or the exposed heme edge 
(3). 
Spectral Properties of Cytochrome c 
0 
Theorell and ~esson (55) investigated the effects of pH on the 
III 
electronic spectrum of cyt c , observing five spectrally distinct 
species in the pH range Oto 14. These species were designated I-V, 
for simplicity, in order of increasing pH. Type I exists only at pH 
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< 1, has a spectrum which closely resembles acid hemin and was proposed 
to have neither protein ligand coordinated to the iron. Cyt cIII has 
never been completely converted to this form; some type II exists even 
in 3 N HCl. 
Type II predominates in the pH range 1 to 2.5 and was proposed to 
have one of the protein ligands bound to the iron. It is characterized 
by an absorption band around 620 nm, the a-band is shifted about 5 nm 
to the blue (to 525 run) and is decreased in intensity and the Soret 
band is also shifted to the blue by about 14 nm (to 395 nm) with an in-
III crease in intensity (relative to native cyt c ). The 620 nm absorp-
tion band in hemoprotein spectra has been demonstrated to be character-
istic of a high-spin ferrihemoprotein complex (56). 
III 
Type III is native cyt c and predominates in the pH range 2.5 
to 9.3. This form has both protein ligands bound to the iron and is 
characterized by a weak absorption band at 695 nm, and maxima at 530, 
408 and 3)5 nm, with a weak shoulder at 565 nm. The weak absorption 
band at 695 nm has been the subject of much investigation. Schejter 
and George (57) suggested this band was an indication of the conforma-
tional integrity of the protein due to its sensitivity to temperature 
and denaturing agents and was found to be absent in polymeric forms of 
cyt c
111 
(58). It was later suggested that this 695 nm absorption band 
20 
was a consequence of ligation of a methionine-sulfur to the heme iron, 
since a similar absorption band was observed when thioethers, including 
N-acetylmethionine, were added to solutions of a heme peptide obtained 
from cytochrome c (59). Eaton and Hochstrasser (60) have shown by ex-
III 
amining single crystal spectra of cyt c that the 695 nm band is z-
polarized and attributed it to a charge transfer transition. The 
methionine-80 sulfur has since been confirmed as the sixth ligand by 
X-ray crystallography (3). Wilson and Greenwood (61) have studied the 
correlation between reducibility and the presence of the 695 nm absorp-
III 
tion band in cyt c 
III 
Type IV cyt c exhibits absorption maxima at 537, 408 and 355 nm 
with a shoulder at 565 nm. The major spectral difference between this 
III 
form and native cyt c is the lack of the 695 nm band. Using high 
resolution nmr spectroscopy, Gupta and Koenig (62) found the broad high 
field absorption near 24 ppm (assigned to the methyl protons of methio-
nine-80 when it is bound to the heme iron) disappears with a pK ~9. 
Further investigation of this alkaline isomerization indicated an 
ionizing group with pK 11.0 binds the iron with an equilibrium constant 
of ~125, resulting in an overall observed pK of ~9 (63). Furthermore, 
h d · 1 f III h" f f O 26 H 7 t ere uction potentia o cyt c s 1 ts rom +. Vat p to 
+0.12V at pH 10, and suggests the ionization of a group with an apparent 
pK of 9.3 (64). The lysyl-79 residue has been proposed as the most 
likely ligand to displace the methionine sulfur under alkaline conditions 
(62,63,65). 
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The final spectral transition occurs with pK ~11 to give type V 
III 
cytc It has been suggested that OH- ion displaces one of the 
ligands, since the spectrum of this species closely resembles alkaline 
methemoglobin (55). This transition is probably not due to dissociation 
of the histidine-18 nitrogen from its axial coordination position, since 
III 
there is no change in the CN-cyt c complex (presumed to have histidine-
18 as one axial ligand and CN as the other axial ligand) with a similar 
pK (62). 
II 
It is interesting to note that cyt c shows the same spectrum 
throughout this pH range. This is due to the fact that Fe(II) is low 
spin and in octahedral symmetry, which is the crucial factor in hemo-
chromogen spectra (66). 
III 
Interaction of Cytochrome c with Iron Binding Ligands 
As a result of their spectroscopic observations, Keilin and Hartree 
(67,68) concluded that cyt cIII did not form a cyanide complex, in con-
trast to other ferriheme proteins. This conclusion was generally 
accepted until Potter (69) reported a decrease in the amount of reduc-
·b1 cIII by the succin1.·c d h d . h f 1. e cyt e y rogenase system 1.n t e presence o 
cyanide. Potter also noted a slight shift from 530 to 535 nm in the ab-
III 
sorption maximum of cyt c in the p r esence of cyanide, further suggest-
ing complex formation. Horecker and Kornberg (70) investigated this 
complex and found that it was indeed stable and, furthermore, caused a 
large decrease in the 695 nm absorption band. Several investigations 
. III since have shown that azide and irnidazole form complexes with cyt c 
as well. 
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George and coworkers (71-73) have studied the reaction of cyt c 
with various ligands quite extensively. Cyt cIII reacts with both HCN 
and CN in the physiological pH range, although the reaction with HCN 
is insignificant compared with that of CN (71). (See Table 1 for 
rate and equilibrium constants). II Cyt c , on the other hand, forms 
complexes with iron binding ligands only at extremely alkaline pH and 
dissociation of the CN ligand was observed upon neutralization of the 
solution. 
Azide (73) and imidazole (74,75) have been shown to interact with 
III 
cyt c and furthermore, an extensive study of rate and equilibrium 
constants for ligand binding to cyt cIII by Sutin and Yandell (76) has 
resulted in a unifying mechanism for complex formation. Since the rate 
of formation of ligand-cyt cIII complexes fall within a limited range 
(see Table 1), the proposed mechanism for complex formation involved a 
rate limiting heme crevice opening or loosening of the methionine-80 
sulfur-iron bond (reaction 1). The first order rate constant for this 
-1 
rate limiting process is 60 sec • The implications of this proposed 
rate limiting crevice opening will be discussed further below. The 
ligand then binds to the heme iron (reaction 2) and the two equilibrium 
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Table 1. Rate and equilibrium constants for ligand binding to cyto-
chrome cIII. Values for azide and imidazole are from refer-
ence 76 and values for cyanide are from reference 71. The 
value of KX is the observed equilibrium constant, Kx' is 
the equiliorium constant calculated for proton dissociated 
ligand at pH 7.0; Kx' = ¾(l + [H+]/Ka). The rate constants 
are determined from the mechanism shown in reactions 1 and 2. 





pH 7.0, µ = 1.0, b- 75 mM phosphate buffer, pH 7.1, µ = 0.16, 
c- 75 mM phosphate buffer, pH 7.4, d- this value was estimated 
by Sutin and Yandell (76). 
¾ 1Sc' kl k2/k_l k_2 
-1 -1 -1 -1 -1 M M sec M sec 
4.5 4.5 31±10 0.82 5.2 
15.3 
3 32 6 60±15 1.3d 2.4 -5 4.3 X 10 1.2 X 10 15.2c 0.5 1.3 X 10 
III* III 
where cyt c is proposed to be a conformational isomer of cyt c 
with the methionine-BO sulfur-iron bond broken, and X represents ligand. 
III A high resolution runr study of cyt c (62) showed that azide does 
III not complex to the alkaline form of cyt c and the azide complex dis-
sociates with a pK ~9, indicating the presence of a different, more 
tightly bound ligand under alkaline conditions (proposed to be the E-
amino group of lysine-79). An esr investigation of the azide and imi-
dazole complexes indicated that both are in the purely low spin state 
between -253 and 23° C (77). 
Redox Reactions with Cytochrome c 
Since the literature pertaining to redox reactions with cytochrome 
c is quite extensive, this survey will be restricted to those studies 
which are most pertinent to this investigation. 
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The rate of reduction of cyt cIII by its physiological reductant, 
II 
cyt c 1 , was found to be slower than expected, giving a second order 
6 -1 -1 
rate constant of 3.3 x 10 M sec at 10° C (78). The rate constant 
for the reverse reaction was 1.0 x 10 6 M-l sec-l under the same con-
ditions (78), giving a value for the equilibrium constant of 3.3, which 
is in good agreement with spectroscopic measurements of K (79). The 
eq 
equilibrium constant was independent of temperature and ionic strength 
but dependent on pH, whereas the rate constants were a function of all 
three properties. 
The oxidation of cyt cII by its physiological oxidant, cytochrome c 
oxidase, under pre-steady state conditions is complex and depends on the 
cyt c:cytochrome oxidase ratio (80). The second order rate constant 
for reduction of the cytochrome a component in the oxidase is 10 6-10 7 M-l 
-1 
sec , depending on the cytochrome oxidase preparation. Van Buuren 
7 et al. (81) determined the rate constant of the reaction to be 6 x 10 
M-l sec-lat 22° C and H 7 2 ili i 1 d 1 i hi p • , ut z ng a pu se ra io ys s teen que. 
Rates of electron transfer from bacterial (Pseudomonas fluorescens) 
III redox proteins, cyt c 551 and azurin (a copper protein) to cyt c have 
been investigated (82). Second order rate constants for the two reac-
4 -1 -1 3 -1 -1 tions are 8 x 10 M sec for cyt c
551 
and 1.1 x 10 M sec for 
azurin, both at 20° C. 
III 






) has been 
studied quite extensively by a number of workers. All of these studies 
indicated that at least two reactions were involved with different 




= reacts with cyt c 
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by two reaction pathways, one being remote attack at the periphery of 
the cytochrome molecule (possibly at the exposed heme edge) and the 
second being adjacent attack at the heme iron which would have a rate 
-1 limited by the rate of opening of the heme crevice (k = 30 sec ). The 
4 -1 -1 rate constant for the remote attack pathway was 1.17 x 10 M sec 
Lambeth and Palmer (84) interpreted the complexity of the reaction 







are in equilibrium in solution. The equilibrium constant, determined by 
-9 esr spectroscopy, had a value of 1.4 x 10 M. The rate constants for 
. III 4 7 






- were 1.5 x 10 and 3.9 x 10 
-1 -1 
M sec , respectively (84). Further evidence for the significance of 
the reaction with so2- was obtained by reduction of other redox compon-
ents by dithionite (e.g. ferredoxin, lumiflavin-3-acetate, plastocyanin 
and ferricyanide) (84). Miller and Cusanovich (85) reported rate 
constants for the reduction of cyt cIII of 2.8 x 10 8 and 6 x 10 5 M-l 
-1 
sec for so2 and s2o4=, respectively, at infinite dilution and pH 7.0. 
Lambeth et al. (86) studied the reduction of cyt cIII by dithionite 
II at pH 10.7 and found that a transient cyt c species is formed with 
more intense absorption characteristics in the visible region. This 
II transient form reverted to the more stable native cyt c with a rate 
-1 
constant of 2 to 8 sec , depending on pH. In addition, they studied 
h d f II b t e rapid oxi ation o cyt c y ferricyanide at pH 10.5 and found a 
III 
transient cyt c species is formed at this pH which has the 695 nm 
III absorption band and an ear spectrum characteristic of neutral cyt c 
III This species is converted to the normal alkaline form of cyt c , lack-
ing the 695 nm band, with a rate constant of 0.8 sec -1 
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The interaction of iron hexacyanides with cytochrome c in both 
oxidation states has been studied quite extensively. Table 2 shows 
II the rate constants reported by several workers for oxidation of cyt c 
III by ferricyanide and reduction of cyt c by ferrocyanide. The equi-
librium for this system has been studied under a variety of conditions 
by several techniques. Brandt et al. (87) found that the rate of reduc-
tion of cyt cIII by ferrocyanide was not affected in the neutral to 
slightly alkaline pH range, although the equilibrium did shift, due to 
the formation of alkaline cyt cIII_ Stellwagen and Shulman (88), using 
nmr spectroscopy, found that both ferri- and ferrocyanide form complexes 
with both oxidation states of cyt c. They proposed a mechanism involv-
ing complex formation between the iron hexacyanides and cyt c prior to 
electron transfer: 
K 
cyt cIII + Fe(II) ~ 
+ Fe(III) 
III k2 II 
cyt c -Fe(II) ~ cyt c -Fe(III) 
k_2 
K3 II 
~ cyt C 
where Fe(III) and Fe(II) represent ferri- and ferrocyanide, respectively. 
-1 -1 
Their value for K1 was 400 M , the values for k 2 
and k_
2 
were 208 sec 
4 -1 
and 2.08 x 10 sec , respectively. The value for k_
2 
was determined 
-1 -1 1 
assuming a value of 400 M for K3 (or K3
- = K
1
). Complex formation 
was further supported by the findings of Miller and Cusanovich (85), 
although their values for the rate and equilibrium constants differed 
quite significantly. Their value for K
1 
was 2.4 x 10 3 M-1 , with a rate 
III 4 -1 -1 of formation of the cyt c -Fe(II) complex being 1.7 x 10 M sec . 
27 
Table 2. Apparent rate constants for oxidation and reduction of 
cytochrome c by iron hexacyanides. All measurements were 
made in the physiological pH range (6.0 to 8.0) and at 20 to 
25° C. k is the apparent rate constant for oxidation of 
cyt c 11 b?xferricyanide and k d for the reduction of cyt 
cIII by ferrocyanide. re 



















Their value for k 2 was 1.5 x 10 sec and the largest discrepency be-
tween their work and that of Stellwagen and Shulman was in the value 
-5 -1 for K3 which they found to be 1.5 x 10 M , indicating the complex 
between cyt c
11 
and ferricyanide was stronger than the complex between 
III 
cyt c and ferrocyanide. 
Equilibrium dialysis measurements have indicated that there are at 
least two binding sites on cyt c for the iron hexacyanides (89). Tri-
fluoracetylation of all of the lysyl residues of cyt c prevents binding, 
indicating that the interaction is primarily electrostatic. Both 
binding sites are eliminated by raising the pH to 10 and one of the 
binding sites is eliminated by carboxymethylation of methionine-BO, 
which presumably causes ligation of a lysyl £-amino group to the heme 
iron (90). It was therefore concluded that lysine-79 was involved in 
28 
binding the iron hexacyanides, which suggested electron transfer through 
the exposed heme edge, since it is in such close proximity to the lysyl-
79 side chain (89). 
The reduction of cyt cIII by transition metal ions has been studied 
by several workers. Kowalsky (95) showed that Cr(II) ion reduces cyt 
cIII rapidly and the chromium becomes bound to the protein, in an 
approximately 0.5 molar ratio of chromium to cyt c, during the course of 
the reaction. Addition of phosphate to the medium resulted in an in-
crease in the ratio of bound chromium to nearly 1.0 and phosphate is 
also bound with a similar ratio. A similar, phosphate specific acti-
vation has been observed in the reduction of cyt cIII by Fe(II) ion 
(96-98). Grimes et al. (99) were able to effect a 1:1 Cr(III)-cyt II C 
complex in the absence of phosphate. Hydrolysis of the complex by 
trypsin and subsequent chromatography yielded two fragments containing 
chromium, which indicated the Cr(III) ion had crosslinked two residues 
of the peptide chain. III Examination of a model of cyt c indicated 
that only two residues of the crosslinked fragments were sufficiently 
close to allow crosslinking to take place. These residues were 
tyrosine-67 and asparagine-52. It was therefore concluded that tyrosine-
67 participates in the reduction of cyt cIII by Cr(II) and it was sug-
gested that this residue may participate in the reduction mechanism 
in vivo. ---
Dawson et al. (100) determined the rate constant for reduction of 
cyt cIII by Cr(II) in NaCl medium(µ= 0.1) at pH 4.8 and 25° C, and 
4 -1 -1 obtained a value of 1.2 x 10 M sec Yandell et al. (101) 
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investigated the rate of reduction of cyt cIII by Cr(II) ion more ex-
tensively and found the reaction is catalyzed by various anions, with 
the order of catalytic activity being Cl-< I ~ SCN. Further-
more, it was found that the rates were not directly proportional to the 
concentration of Cr(II), but tend to a limiting value at high concen-
trations of Cr(II). Two mechanisms were suggested to account for such 
behavior; one involving a conformational change in the cyt cIII, which 
becomes rate limiting at high Cr(II) concentrations, the second involves 
III 
complex formation between cyt c and Cr(II) and subsequent electron 
transfer, which also becomes rate limiting at high Cr(II) concentrations. 
The order of the catalytic activity and the nature of the anions in-
volved suggested that electron transfer proceeds via remote attack, 
probably at the exposed heme edge or through the aromatic residues (101). 
The reduction of cyt cIII by Fe(EDTA) 2- is first order in both re-
actants over a wide range in concentration of reductant with a rate con-
4 -1 -1 
stant of 2.57 x 10 M sec in pH 7.0 phosphate buffer,µ= 0.10 
with NaCl and at 25° C (102). Kinetic studies at pH 9 indicated this 
reductant reacts with two slowly interconverting forms of the protein 
(102). The rate constant for the reduction of the alkaline form was 
26.7 M-l -1 sec These kinetic results suggested an outer sphere mechan-
ism with the probable site of attack at the exposed heme edge. 
III Ewall and Bennett (103) studied the reduction of cyt c by 
2+ 
Ru(NH 3) 6 ion which is classified as an outer sphere reductant. The 
reaction was first order in both reactants over a wide range in concen-
tration of reductant. Although the rate law included a hydrogen ion 
30 
dependent term, this was insignificant at neutral pH and the rate con-
4 -1 -1 
stant obtained was 3.78 x 10 M sec • Creutz and Sutin (104) found 
III that the pentaamminebenzimidazoleruthenium(II) ion reduced cyt c much 
faster than the hexaammine complex with a rate constant of 4.7 x 10 5 M-l 
-1 
sec at pH 6.1 andµ= 1.0. 
III Greenwood and Palmer (74) studied the reduction of cyt c at 
varying pH on the alkaline side of neutrality and provided further evi-
dence for the existence of two functionally distinct forms of cyt c in 
this pH region. They found that ascorbate and tetrachlorohydroquinone 
III react with only the native form of cyt c and were able to determine 
the rate of interconversion of these two forms. The rate constants for 
the reaction with these two reductants were very different at pH 8.0 in 
this buffer, varying by several orders of magnitude. The values of the 
2 6 -1 -1 rate constants were 7.5 x 10 and 6 x 10 M sec for ascorbate and 
tetrachlorohydroquinone, respectively. The rate constant for conversion 
III -1 from native to alkaline cyt c at pH 10.0 was 0.188 sec and the rate 
constant for conversion back to the native form at pH 7.6 was 0.048 sec 
-1 
sec , both at 21° C (74). 
III 
The reduction of cyt c by hydroquinone is much slower than the 
rate with tetrachlorohydroquinone. The rate constant for hydroquinone 
-1 -1 
reduction is 3.7 M sec (105), with the semiquinone radical formed 
in the reaction causing autocatalysis, indicating its reaction with 
III 
cyt c is much faster (a rate constant was not determined). 
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Some of the fastest reactions reported for cyt care its reduction 
by radical species produced in aqueous solution by pulse radiolysis. 
III Several groups have studied the reduction of cyt c by the hydrated 
electron produced by pulse radiolysis and the rate constants are in 
reasonable agreement, varying from 2-10 x 10 10 M-l sec-l are neutral pH 
and 20° C (106-109). As expected for two oppositely charged species, 
the rate is dependent on the ionic strength of the medium, the lower 
values observed in 0.1 M ionic strength (106,107) and the larger values 
observed in distilled water (108,109). 
The reduction of cyt cIII by the hydrogen atom is also very rapid, 
but the rate is independent of ionic strength. The rate constant deter-
mined for this reaction is 1.0 x 10 10 M-l sec- 1 , and is the same for 
hydrogen atoms produced by pulse radiolysis (110) or by an external 
hydrogen generator (111). 
III Wilting et al. (106) found that at high concentrations of cyt c 
(>20 µM) the rate of reduction by the hydrated electron becomes limiting 
by a first order process. The following mechanism was proposed for the 
reaction in 3.3 mM phosphate buffer (pH 7.2, 21 ° C) : 
III kl III k2 II* k3 II e + cyt C 
~ e -cyt C -->cyt C -->cyt C aq 
where kl 4.5 1010 M-1 
-1 
k_l < 
4 -1 6 -1 = X sec 10 sec , k2 = 5 x 10 sec and , 
-1 
sec According to this mechanism, a transient complex 
III is formed initially between the hydrated electron (e ) and cyt c 
aq 
II* which undergoes intramolecular electron transfer to form cyt c , which 
is an unstable form of reduced cyt c. This reduced species then 
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II undergoes a conformational change to form the stable cyt c species. 
III This mechanism argues in favor of electron transfer to cyt c involving 
the aromatic amino acid residues, such as tyrosine-67 (106). 
Land and Swallow (108) have reported the rate constants for the re-
III 
duction of cyt c by various radicals produced by pulse radiolysis. 
The CO2 radical is produced from formate and gives a rate constant for 
d i f C III of 5 x 10 8 M-l sec-l. re uct on o cyt The rate increases by 
nearly a factor of 10 below pH 4, which was attributed to protonation 
of the radical, forming the more reactive COOR radical. The superoxide 
anion radical reduces cyt cIII with a rate constant of 1.1 x 10 5 M-l 
-1 
sec at pH 8.5. The protonated form of superoxide, H0
2
, is relatively 
III 
unreactive with cyt c • 
Studies with Modified Cytochrome c Species 
Since the three dimensional structure of cytochrome c has been 
elucidated in both the oxidized (3) and reduced (4) states, this protein 
has been especially useful in the study of structure and function re-
lationships. One approach in such studies has been in the selective 
modification of amino acid residues within the protein. This approach 
has been simplified by the advancement of techniques designed to mea-
sure cytochrome c reactivities with cytochrome c oxidase (112) and NADH-
cytochrome c reductase (113) systems independently as well as measuring 
activities in cytochrome c depleted mitochondria (114,115). Naturally 
the more interesting results have occurred by modification of the amino 
acid residues in and around the heme crevice. 
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Modification of the single tryptophan residue in cyt c (trp-59) 
has been accomplished using a variety of group specific reagents. 
Aviram and Schejter (115) first described the formylation of the indole 
nitrogen using formic acid in the presence of HCl. The modification was 
reversed by incubating the formyl-cyt cat pH 11 for 30 min. Formyl-
III 
cyt c lacks the 695 nm absorption band, has the Soret maximum shifted 
3 nm to the blue (406 run) and is not reduced by ascorbate at pH 7, 
but is reduced by dithionite, although much more slowly than the native 
protein (115). The reduced protein is autoxidizable and binds CO at 
neutral pH (115). These characteristics indicated that methionine-BO 
is not bound to the heme iron in this modified protein even though the 
modification procedure does not chemically alter the methionine. Since 
tryptophan-59 is involved in hydrogen bonding with one of the propionic 
acid side chains of the porphyrin, forrnylation of the indole nitrogen 
would necessarily break this hydrogen bond, apparently causing gross 
conformational changes to take place in the protein (115). Thermal 
denaturation studies, circular dichroism and electronic absorption 
III 
spectra have indicated that formyl-cyt c not only has an altered co-
ordination configuration of the metal but produced a grossly deranged 
molecular conformation (116). 
Erecinska (117) found that a single species of formyl-cyt c could 
be isolated by ion exchange chromatography, which had a midpoint poten-
tial of 0.085 Vat pH 7.0. (Potential measurements of the formyl-cyt c 
preparation prior to purification, exhibited a sigmoid titration curve 
characteristic of two components with resolved midpoint potentials of 
34 
0.090 and -0.055 V). This purified preparation was reduced by ascorbate 
(in contrast to the preparation of Aviram and Schejter), was reactive 
with cytochrome c oxidase (although the K was 6 fold greater than for 
m 
native cytochrome c and the apparent V was smaller) but did not restore 
respiratory activity to cytochrome c depleted mitochondria. The formyl-
III 
cyt c was not reactive with purified mitochondrial NADH-cytochrome c 
reductase, which is not surprising since the reaction is not thermody-
namically favorable; it was, however, reactive with purified microsomal 
NADPH-cytochrome c reductase which is known to have a lower reduction 
potential, although the rate is approximately 20% that observed with 
native cyt cIII (117). 
Brittain and Greenwood (ll8) have reported a kinetic investigation 
of the reduction of formyl-cyt cIII by Cr(II) ion as well as the rates 
of ligand binding with CO and NO as ligands. At pH 6.3, the reduction 
is biphasic with one phase dependent on the concentration of Cr(II) 




) and one phase independent (k = 5.0 sec- 1 ). 
III Similarly the reaction of NO with formyl-cyt c is biphasic with one 
phase dependent and the other independent of NO concentration with rate 
3 -1 -1 -1 
constants of 2.8 x 10 M sec and 0.2 sec , respectively. The re-
II 
action of formyl-cyt c with CO is also biphasic; both phases however, 
are dependent on the concentration of CO with rate constants of 1.8 x 
10
2 
M-l sec-land 1.6 x 10
3 
M-l sec- 1 • Dissociation of the CO by pho-
tolysis and subsequent recombination resulted in a simple second order 
2 -1 -1 reaction with a rate constant of 1.9 x 10 M sec • A scheme was pro-
posed to account for such kinetic behavior ~hich involves a slow 
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II equilibrium between two forms of the formyl-cyt c both of which re-
II 
act with CO to form a single formyl-cyt c -CO complex which dissociates 
upon photolysis to give only one of the forms (the slower reacting one), 
and a subsequent recombination reaction which is fast in comparison with 
the equilibrium. Although no data was presented for the reactions with 
III 
formyl-cyt c (Cr(II) reduction or NO binding), the authors suggested 
that the reduction of formyl-cyt cIII indicates a reductive step and 
subsequent conformational change. It should be pointed out, however, 
that their preparation procedure was essentially that of Aviram and 
Schejter (115) which would not have separated the two components of dif-
ferent reduction potential reported by Erecinska (117). 
Sokolovsky et al. (119) found that cytochrome c could be nitrated 
with tetranitromethane at pH 8.0 and a protein modified specifically at 
the tyrosyl-67 residue could he purified. This nitro derivative is 
unable to restore respiratory activity to cytochrome c depleted mito-
chondria (119). The purified nitro-cyt cIII was found to be in the 
purely high spin state in acid medium and in the low spin state in 
alkaline medium; at intermediate pH values, two forms exist, one with 
high spin and the other with low spin characteristics (120). The low 
spin form is ascorbate reducible, but has a heme linked pK of 5.9 in-
stead of the pK 9.0 of the native protein. The other form is not re-
duced by ascorbate and remains in the high spin state up to pH 8.6. 
Both forms are autoxidizable and bind CO. 
A more rigorous purification procedure allowed the separation of a 
mononitromonotyrosyl-cytochrome c derivative (MNMT-cyt c) with modifi-
cation of tyrosine-67, and a mononitrodityrosyl-cytochrome c (MNDT-cyt c) 
36 
with the additional modification of tyrosine-48, from the tetranitro-
methane reaction mixture (121). III The MNMT-cyt c has spectral charac-
III teristics very similar to the native cyt c ; the 695 nm absorption 
band, however, has an extinction coefficient, a ·t pH 4.5, approximately 
60% that of the native cytochrome and the 695 nm band disappears with a 
pK of 6.2, in contrast to the native protein which loses its 695 run band 
with a pK of about 9.0 (121). III The MNDT-cyt c does not exhibit the 
695 nm band at all. The MNMT-cyt c is ascorbate reducible, shows about 
24% activity with NADH-cytochrome c reductase, about 82% activity with 
cytochrome c oxidase and is slowly autoxidized. The MNDT derivative 
on the other hand, is not reduced by ascorbate, shows little or no 
activity with NADH-cytochrome c reductase and is autoxidized too rapidly 
to determine its activity with cytochrome c oxidase (121). Circular 
dichroism spectra indicated that the MNMT-cyt cIII is conformationally 
very similar to the native protein, although at neutral pH it resembled 
III 
the alkaline form of cyt c quite closely. The MNDT-cyt 
III 
C at 
neutral pH represents a form with altered iron coordination as well as 
deranged protein conformation (121). 
Aviram and Schejter (122) found that pyridoxal phosphate could be 
covalently bound to cytochrome c by borohydride reduction, giving two 
derivatives which could be separated by ion exchange chromatography. 
These two derivatives were found to have one or two residues of pyri-





cyt c, respectively. Both modified proteins show cytochrome c oxidase 
activity nearly identical with native cyt c 11 but the activities with 
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PLP 2- cyt c , respectively (122). Proteolytic digestion of these cyt 
c derivatives and subsequent purification of the fragments indicate 
pyridoxal phosphate is covalently bound to three peptide fragments 
corresponding to the partial sequences: 1-10, 68-74 and 83-94 (122). 
Since the amino terminal end of cyt c is acetylated, only the lysine 
residues would be susceptible to modification with pyridoxal phosphate 
and borohydride. The PLP-bound peptides 1-10 and 83-94 have three 
lysyl residues each, which define a positive region at the top portion 
of the molecule (see Figure 2) and the peptide 68-74 has two lysyl 
residues which are located in a different section of the molecule. It 
was concluded that these two regions of the molecule are possible sites 
of interaction with the reductase system, but must not be involved in 
the reaction with cytochrome c oxidase. Further studies of PLP-modified 
cytochrome c have not appeared in the literature. 
Several other derivatives of cytochrome c have been prepared (e.g. 
see 51); limited space and their irrelevancy to this study, however, 






The synthesis of di-µ-oxo-bis[oxo(L-cysteinato)molybdate(V)] 
(complex I) has been reported by Kay and Mitchell (16). L-Cysteine 
hydrochloride (3.2 g) in 5 ml of water was added to sodium molybdate 
(5.1 g) in 8.3 ml of water. While stirring with a magnetic stirrer, 
sodium dithionite (1.5 g) in 6.5 ml of water was added and the mixture 
stirred for 15 min. It was then vacuum filtered in a buchner funnel and 
washed once with 1:1 (v/v) ethanol-water. The residue was dried by 
suction of prepurified N2 through the crystals. The complex was re-
crystallized once prior to use by dissolving the crystalline solid in 
a minimum amount of hot water and adding ethanol until a precipitate 
just formed. The solution was heated to boiling and then cooled. The 
precipitate was vacuum filtered, washed twice with 1:1 (v/v) ethanol-
water and dried by suction of prepurified N
2 
through the crystals. The 
crystals were further dried in an oven at 60° C for 3 to 4 hr. 
The purity of the complex was checked by weighing some of the dried 
solid and dissolving in pH 7.0 phosphate buffer which had been deaerated 
with prepurified N2 • The absorption spectrum has a maximum at 306 nm 




The µ-oxo-bis[oxodihydroxo(L-cysteinato)molybdate(V)] (complex II) 
was prepated in situ from complex I in pH 10 borate buffer in the 
presence of a 20 fold excess of L-cysteine unless noted otherwise. 
Under these conditions (with a 20 fold excess of L-cysteine), the bridge 
opening goes essentially to completion in 3 hr (21). Due to the sensi-
tivity of complex II to air oxidation, solutions deaerated with pre-
purified N2 were prepared immediately prior to use (within 2 to 3 hr) 




The Mo(V)-penicillamine complex (I-pen), analogous to complex I, 
was prepared in the same way as complex I, substituting D,L-penicillamine 
for L-cysteine. D,L-penicillamine (0.80 g) was dissolved in a minimum 
amount of pH 2 aqueous HCl (ca. 10 ml) to which was added 1.3 g sodium 
molybdate and the mixture stirred with a magnetic stirrer. After mixing, 
0.35 g sodium dithionite was added and the mixture stirred for 15 min. 
The complex did not precipitate until ethanol was added. The solution 
was cooled to 0° C and filtered in vacuo. 
The penicillamine complex was recrystallized by dissolving it in a 
minimum amount of 0.1 N HCl. Ethanol was added until a precipitate just 
persisted and the mixture heated to boiling and cooled. The complex 
was vacuum filtered and dried by suction of prepurified nitrogen through 
the crystals. The solid was further dried in an oven at 60° C for 3 to 
4 hr. There is always a small amount of free penicillamine present in 
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the crystallized complex as will be shown in the results, although the 
residual free penicillamine was generally less than 2 %. 
The monoxobridged Mo(V)-penicillamine complex (II-pen), analogous 
to complex II, was prepared by dissolving tle sodium salt of the di-
bridged complex in 0.25 M borate buffer at pH 10. The concentration of 
-3 the dibridged complex initially was 2.0 x 10 M. The solution was 
allowed to stand at room temperature for 24 hr in the presence of excess 
L-cysteine under prepurified N2 . Approximately 80% of the dibridged 
species disappeared as evidenced by the disappearance of its polaro-
graphic wave. The addition of flavin mononucleotide to this solution 
shows that only 60% of the molybdenum added initially is reactive with 
flavin (123). A different preparation under identical conditions showed 
less than 30% of the total molybdenum present to be reactive with cyto-
III 
chrome c in a rapid reaction. The concentration of active molybdenum 
(assumed to be monoxobridged Mo(V)-penicillamine) was determined from 
III 
the amount of cyt c rapidly reduced in the presence of less than one 
equivalent of the active species. 
Cytochrome c and derivatives 
Horse heart cytochrome c (types III and VI) was obtained from 
Sigma Chemical Co. (St. Louis, Mo.) and used without further purification. 
Type III cytochrome c was used in all modification procedures. Kinetic 
III results were the same with either type III or type VI cytochrome c and 
the two were used interchangeably. The concentration of native cyto-
chrome c was determined from the molar absorptivity at 550 nm after com-
plete reduction, using an extinction coefficient of 27,700 (124). 
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N-formyltryptophyl-cytochrome c. Cytochrome c was formylated at 
the tryptophan-59 residue by the method of Aviram and Schejter (115). 
Cytochrome c (50 mg) was dissolved in 2.0 ml formic acid (97+ %) to 
which 2.0 ml formic acid saturated with HCl was added. The mixture 
stood at room temperature for 90 min and the mother liquor was removed 
in vacuo. The protein residue was then dissolved in a minimum amount of 
pH 3 aqueous HCl and chromatographed on a Sephadex G-25 column (2.5 x 
15 cm) to remove residual reagent. The original procedure recommends 
lyophilization at this stage; the lyophilized protein, however, is not 
very soluble and the preparative procedure was modified. The eluant 
from the gel filtration was dialyzed against 0.02 M phosphate buffer, 
pH 7.5. The dialyzed protein was then adsorbed on an Amberlite CG-50 
ion exchange column (1.5 x 20 cm), washed with 2 to 3 vols of 0.02 M 
phosphate buffer, pH 7.5 and eluted with 0.40 M phosphate buffer, pH 
7.5. The single protein band which was eluted was characterized as 
formyl-cyt c
111 
by its characteristic absorption spectrum, which lacks 
the 695 nm absorption band and has the Soret maximum at 406 nm. 
The concentration of formyl-cytochrome c solutions was determined 
by the absorbance of the fully reduced cytochrome at 550 nm using an 
extinction coefficient of 21,300 (117). The stock solution of formyl-
111 cyt c was stored at ca. 4° C until used. 
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Pyridoxal-5'-phosphate modification of cytochrome c. Cytochrome c 
was modified with pryidcxal-5'-phosphate (PLP) by the procedure of 
Aviram and Schejter (122). Cytochrome c (50 mg) and 4.5 mg PLP were 
dissolved in 10 ml of 0.05 M tris-cacodylate buffer, pH 8.0. After 7 
min in solution, 0.7 ml of 0.40 M NaBH
4 
in 0.02 M NaOH was added to give 
a final concentration of NaBH4 of ca. 25 mM. After 15 min the mixture 




added to oxidize the cytochrome 
c. The solution was placed under vacuum for 10 min to remove excess 
hydrogen. The protein solution was then adsorbed on an Amberlite CG-50 
column (2.5 x 12 cm), equilibrated with 0.02 M phosphate buffer, pH 8.0. 
After all of the protein was on the resin, the column was washed with 
4 to 5 volumes of the ~quilibrating buffer and then eluted with a Oto 
0.6 M NaCl gradient in 0.02 M phosphate buffer, pH 8.0. Fractions were 
collected (5 ml each) ~nd the absorbance of each fraction measured at 
530 and 320 nm. The elution profile was plotted for both wavelengths as 
well as the ratio A320 :A530 vs fraction number (Figure 3). Aviram and 
Schejter (122) found QY amino acid analysis that the protein fractions 
with an A320 :A530 ratio of 2.5 contained 2 PLP groups per cytochrome c 
molecule and the protein with a ratio of 2.0 contained 1 PLP group per 




ratio for native cytochrome c is 
approximately 1.4. The fractions with A320 :A 530 
ratios near 2.5 were 




and fractions with ratios near 2.0 were taken 
I I I bj h . . d 1 . Be to be PLP
1
-cyt c without su ecting t em to amino aci ana ysis. -
cause the PLP derivatives had very little affect on the kinetics with 




























10 20 30 40 50 60 
Fraction Number 
Elution profile for chromatographic purification of 
PLP-cyt clll derivatives on Amberlite CG-SO. • -Absorhance 
at 320 nm, •ahsorhancc at 530 nm, •-the ratio of A320:As30• 
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III All PLP-cyt c solutions were 0.10 M phosphate buffer, pH 7.0, 
µ = 0.50 (adjusted with NaCl). 
Nitration of cytochrome c. The mononitromonotyr~syl derivative of 
cytochrome cIII (MNMT-cyt cIII) was prepared according to the method of 
Sokolovsky et al. (119). Cytochrome c (50 mg) was dissolved in 20 ml 
of 0.10 M tris-HCl buffer, pH 8.0. Tetranitromethane (0.023 ml, 31.4 
mg) was dissolved in 0.5 ml ethanol and this solution was added to the 
cytochrome c s-0lution and allowed to stand at room temperature for 35 
to 40 min. The mixture was chromatographed on Sephadex G-25, which had 
been equilibrated with 0.02 M phosphate buffer, pH 7.5, to stop the 
reaction and remove excess reagent. The eluant · containing most of the 
protein was diluted to 50 ml and adsorbed on an Amberlite CG-50 column 
(2.5 x 15 cm) equilibrated with the same buffer as the Sephadex column. 
The column was washed with 3 to 4 volumes of equilibrating buffer and 
eluted with a Oto 0.3 M NaCl gradient in 0.02 M phosphate buffer, pH 
7.5. Fractions (11 ml each) were collected and their absorbance 
measured at 530 nm. The elution profile is shown in Figure 5. The 
absorption spectra were recorded ior fractions at the maxima in the 
elution profile. 
The spectral and chemical properties of fraction Care given in 
III 
Table 3 and are consistent with the properties of MNMT-cyt c reported 
by Pal et al. (121). The spectral characteristics are not easily dis-
tinguishable from native cytochrome c; its chemic al characteristics, 
' III 
however, indicate that this fraction is MNMT-cyt c as reported by 
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Figure 4. Elution profile for chrornatop,raphic purification of 
nitrated cytochrome con Amberlite CG-50. 
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Table 3. Physicochemical properties and activity of native and various 
modified preparations of cytochrome cat neutral pH 
Property 
Spectrum 
III cyt C 
cyt C 
Soret max (nm) 
E (Soret, mM) 
695 nm band 
II 












Ascorbate reducibility Fast 
Autoxidizability None 
Cytochrome c 
reductase activity(%) 100 
Cytochrome c 











































a--reference 116; b--reference 122; .£_--reference 121; d--reference 117. 
Complete reduction can be attained with sodium dithionite and the com-
pletely reduced cytochrome is autoxidizable, which is a characteristic 
native cytochrome clacks. The oxidation is extremely slow with an 
estimated first order rate constant of 1.3 x 10- 4 sec-l in a solution 
saturated with o2 . The autoxidation goes to >85% completion. These 
III 
results indicate the MNMT-cyt c fraction contains approximately 10% 
impurity. 
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All chemicals used in the preparation of molybdenum complexes and 
buffers were reagent grade. Penicillamine was 99+% and tetranitro-
methane was 98%, both purchased from Aldrich Chemical Co., L-cysteine 
(free base) was purchased from Nutritional Biochemicals Corp. and 
pyridoxal-5'-phosphate was purchased from Sigma Chemical Co. The water 




Reduction of cyt c by complex I 
Stock solutions of the reactants were prepared with deaerated 
buffer and maintained anaerobic by continuously passing prepurified N
2 
III through them. Prepurified N2 was generally passed over the cyt c 
solution and bubbling kept to a minimum to prevent denaturation of the 
protein. The stock solutions were kept in a constant temperature bath 
and appropriate amounts transferred to a stoppered, deaerated spectro-
photometer cell with gas tight syringes. The spectrophotometer cell 
was maintained at constant temperature with a water jacketed cell 
holder. Absorbance at 550 and 695 nm was recorded as a function of time 
on a Varian Techtron 635 spectrophotometer equipped with a Hewlett-
III Packard X-Y recorder. The reduction of modified cyt c species by 
III complex I was followed in a similar mann r. The reduction of cyt c 
by the dibridged Mo(V)-penicillamine complex was followed similarly. 
III 
The reduction of cyt c by penicillamine was followed on the 
stopped flow spectrometer equipped with an X-Y recorder. The instrument 
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was equipped in the same way as with the studies of the reduction by 
complex II (vide infra). 
III 
Binding studies with cyt c 
and complex I 
A Sephadex G-25 column (2.5 x 20 cm} was equilibrated with 0.20 M 
phosphate buffer, pH 7.0, µ = 0.53 with NaCl, placed in the cold room 
and about 10 volumes of deaerated buffer, kept under prepurified N
2
, was 
passed through the column to remove oxygen. The reactants were mixed to 
-4 III give final concentration of 1.9 x 10 M for both cyt c and complex I 
in the equilibrating buffer. All procedures were done in deaerated 
buffer and fractions were collected and their absorption spectra recorded. 
The cytochrome c fraction eluted in <30 ml and there was no indication 
III of complex I being present in the cyt c fraction. Less than 30% re-
III 
duction of cyt c took place on the column. Complex I was eluted in 
50 to 90 ml of eluant, and approximately 85% of the total complex I 
added to the column was recovered in these fractions. 
A technique known as the Hummel-Dryer method (125) was also employed. 
A Sephadex G--25 column (1.0 x 10 cm) was equilibrated with a deaerated, 
4 x 10--
4 
M solution of complex I in 0.02 M phosphate buffer, pH 7.0, 
by passing several volumes of the solution through the column. The 
column outlet was connected directly to a 1.00 nnn flow spectrophotometer 
cell in the Varian model 635 spectrophotometer to monitor the absorbance 
of the · eluant at 305 nm (the absorbance maximum for complex I). If com--
III 
plex I binds to cyt c , the absorbance should show a peak where the 
III 
cyt c passes through the cell, followed by a trough due to a decrease 
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in the concentration of I in its wake. A peak was observed for the 
III 
cyt c due to its absorbance in the 305 nm region; however, no trough 
followed, indicating lack of binding. 
II Electronic absorption difference spectra were rec ,Jrded for cyt c 
and complex I, mixed vs separated. Compartmented quartz cells with 
1.00 cm pathlength per compartment, 2.00 cm pathlength overall, were 
used in this study. II The final concentrations for I and cyt c were 
both 4.00 x 10-
5 
Min each cell. The two were mixed in one compartment 
of the sample cell with buffer in the second compartment. The two were 
placed in separate compartments in the reference cell and the difference 
spectrum recorded. There was no significant deviation from the baseline 
in the difference spectrum. 
III 
Reduction of cyt c by complex II 
The stock solution of complex II was prepared as previously des-
cribed (19). III The cyt c stock solution was prepared ~ith deaerated 
buffer and both stock solutions were kept in a constant temperature bath 
under prepurified N2 . The absorbance at 550 nm was followed on an 
Aminco-Morrow stopped flow spectrometer, equipped with a constant tem-
perature circulating system. The loading syringes were maintained 
anaerobic by constantly passing prepurified N
2 
through them and nitrogen 
was continuously passed around the mixing chamber c ompartment. The 
spectrometer was flushed several times with deaerated buffer prior to 
use to remove oxygen. 
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The proper amounts of deaerated stock solutions and buffer were 
transferred to the loading syringes with gas tight syringes and measure-
ments were made as rapidly as possible (1 to 2 min). At least three 
runs were recorded at each concentration and the superimposed oscil-
loscope tracings were photographed. The dead time of the instrument is 
3 to 4 msec. 
Complex II was prepared from I in the presence of added cysteine 
(20 fold excess to catalyze the bridge opening and inhibit hydrolysis) 
(19) for most runs. III Cysteine itself reduces cyt c slowly, with a 
rate constant of ca. -1 -1 0.2 M sec at pH 7.45 (126). The reduction of 
III 
cyt c by concentrations of cysteine that would be found in complex II 
solutions was checked and found to be much too slow to be significant 
with respect to the reduction by II. Complex II, prepared in the absence 
III 
of cysteine, was found to reduce cyt c at the same rate as II prepared 
in its presence. 
Complex II is in a slow, pH dependent equilibrium with complex I 
(21). The rate of conversion of II to I was determined at pH 7.0 by 
monitoring the absorbance change at 305 nm (due to appearance of I). The 
-4 -1 observed rate constant (k = 1.2(±0.2) x 10 sec ) indicates the amount 
of II converted to I, from the time II is diluted in the loading syringe 
until the reaction is recorded (1-2 min), is negligible. The reduction 
III 
of ligand bound and modified cyt c species by complex II was followed 
III in the same way as the reduction of native cyt c • The reduction of 
III 
cyt c by the monobridged Mo(V)-penicillamine complex was followed 
similarly. 
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Potentiometric titration of complex II 
Janus Green Bin 0.02 M borate buffer, pH 8.0, µ = 0.10 (adjusted 
with NaCl) was placed in the potentiometer cell and deaerated with argon. 
An appropriate amount of stock solution of II was transferred to the 
potentiometer cell in a gas tight syringe to give a final volume of 5.0 
-6 ml. The final concentration of Janus Green B was 5.0 x 10 Mand the 
-4 final concentration of II was 1.00 x 10 M prior to titrating. 
The oxidant solutions were placed in the reservoir of the automatic 
titrator (Figure 5) and deaerated with argon. The automatic ti~rator was 
flushed several times with the deaerated oxidant solution, to remove 
oxygen, prior to connecting it to the potentiometric cell containing com-
plex II solution. 
The potentiometric titration was recorded on a Metrohm model E336A 
potentiograph equipped with a model E436D automatic titrator. A Brink-
mann EA234 combination platinum silver-silver chloride electrode was 
employed as the measuring/reference electrode. The automatic titrator 
added 1.00 ml of oxidant solution at a rate of 0.50 ml/min or 0.25 
ml/min. 
Three redox dyes were used as oxidants: methylene blue, pyocyanine 
and thionine. These three dyes were chosen because they are reduced by 
complex II very rapidly but show no detectable reduction in the presence 
of cysteine alone, thereby avoiding any complication which would be 
caused by the excess cysteine present in the complex II solution. Janus 
Green B was selected as a mediator since it was found to be only par-
tially reduced by a slight excess of complex II. Titrations were also 





for chart on ~ 
potentiograph 
rr1r19 bar 
oo Automatic tttrator motor 
Figure 5. Potentiometric titration apparatus (potentiograph not 
shown). 
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Potentiometric titration of native 
and ligand bound cyt cIII 
53 
h . i i i f . III d. d · h Te potentiometr ct trat on o native cyt c was stu ie int e 
absence of any heme iron binding ligands to insure the accuracy of the 
method and apparatus being used. The same general procedure was used 
for measuring the ·redox potential of the cytochrome c system that was 
used for complex II potential measurements (see Figure 5). 
III 
Cyt c was dissolved in 0.02 M phosphate buffer, pH 7.0, µ = 0.50 
(adjusted with NaCl) which had been deaerated with argon. 2,6-Dichloro-
III phenolindophenol (DCIP) was added to the cyt c solution was a medi-
ator to give a final concentration of DCIP of less than 5% the final 
III concentration of cyt c The reductive titration was accomplished 
with either reduced phthiocol or ascorbate as reductant in the same 
buffer system which had been deaerated with argon. III The cyt c solu-
tion obtained in the reductive titration was then back titrated with 
K3Fe(CN) 6 as oxidant. The concentration of cyt c and DCIP mediator were 
15-20% less in the back titration due to the dilution caused by 
the initial reductive titration. The amount of reductant added in the 
initial titration was such that there was not a large excess of reduc-
tant present at the beginning of the back titration. 
III The redox potential of ligand bound cyt c was measured in the 
III same way as the redox potential of native cyt c The redox potential 
of the imidazole-cyt cIII complex (Im-cyt cIII) was determined in 0.02 M 
phosphate buffer which was 0.50 Min imidazole, pH 7.0, µ = 0.35. The 
concentration of cyt cIII was 7.5-15.0 x 10- 5 M with 2.0 x 10- 6 M DCIP 
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III added as mediator. The redox potential of the azide-cyt c complex 
III 
(N3-cyt c ) was determined in o.02 M phosphate buffer which was 0.50 M 
III in NaN3 , pH 7.0, µ = 0.60. The concentration of cyt c was 7.0-7.7 x 
10-
5 
M with 2.0 x 10-
6 
M DCIP added as mediator. The reductive titration 
of both the imidazole and azide complexes was accomplished with reduced 
phthiocol as titrant. 
Phthiocol was reduced electrolytically just prior to titration. A 
5.0 mM solution of oxidized phthiocol in 0.02 M phosphate buffer, pH 7.0, 
µ = 0.10 (with NaCl) was deaerated in the coulometer cell. The potential 
was supplied by a Princeton Applied Research model 173 coulometer at 
-.650 V vs a silver-silver chloride reference electrode. The number of 
coulombs used to reduce the phthiocol was used to accurately determine 
its concentration and was generally within 2 or 3% of the concen-
tration determined from the amount of phthiocol added. The proper 
amount of reduced phthiocol solution was then transferred with a gas 
tight syringe to the titrant reservoir of the automatic titrator. The 
diluting buffer in the titrant reservoir was the same as the buffer 
III 
system for cyt c , including ligand, and was deaerated with argon. 
III III The redox potential of the cyanide-cyt c complex (CN-cyt c ) 
was not determined by potentiometric titration because no redox dye was 
found to reduce the complex rapidly. The redox potential of CN-cyt 
cIII has been estimated at ca. -0.40 V (72), since it is reduced by 
sodium dithionite (E '= -0.46 V) but not by cysteine (E ' = -0.34 V). 
0 0 
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Electron spin resonance studies 
III The fast, second order phase in the reduction of Im-cyt c by 
complex II suggested that a Mo(V) monomeric species may be involved in 
the reaction, since the fast phase was noticeable only at higher con-
centrations of II. A previous esr investigation of complex II (19) 
indicated less than 1% esr active monomeric Mo(V) at pH >8.0, with the 
maximum esr signal observed above pH 11.0. If a Mo(V) monomeric species 
III is involved in the rapid reduction of Im-cyt c , its concentration 
would have to be >1% to account for the fast phase of the reaction. It 
was therefore suspected that imidazole may stabilize the Mo(V) monomer. 
A solution of K3Mo(CN) 8 in 1 N H2
so
4 
was used as a standard for the 
determination of Mo(V) monomer concentration. 3-The Mo(CN)
8 
was pre-
pared in situ from K4Mo(CN) 8 •2H 20 in 1 N H2
so
4 
by oxidation with 0,10 M 
eerie ammonium sulfate (127). The method for determination of concen-
tration of monomer is based on the fact that the area under the esr 
absorption curve is proportional to the concentration of unpaired elec-
trons. Since K3Mo(CN) 8 is present as 100% monomer in solution (128), a 
comparison of the area under the absorption curve for a known concen-
3-
tration of Mo(CN) 8 with the area under the absorption curve for an 
unknown concentration of Mo(V) monomer permits the estimation of the 




solution in the dark, due to its photosensitivity. 
-s 




solution, frozen in 
liquid N2 , was recorded and the area under the first derivative 
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absorption curve was determined by double integration. The concentration 
of the unknown species was calculated from the equation: 
C td x A k x SL d s un st 
A d x SL k st un 
where C = molar concentration of the unknown sample, unk 
The 
C = molar concentration of the standard sample, std 
A = area under the absorption curve of the unknown sample unk 
in arbitrary units, 
Astd = area under the absorption curve of the standard sample in 
arbitrary units, 
SL = signal level for the esr measurement of the unknown and unk 
SLstd = signal level for the esr measurement of the standard. 
determination of g values was not necessary for this study. 
A solution of 1.0 X 10- 3 M complex II in 0.16 M phosphate, 0.40 M 
imidazole buffer, pH 7.1, was added to the esr tube under anaerobic 
conditions and frozen in liquid N
2 
1 min after mixing (the approximate 
time for II in imidazole solutions for kinetic runs). The esr spectrum 
was recorded and the area under the first derivative curve determined 
in the same way as for the standard. 
III 
The esr spectrum of a mixture of cyt c and complex I was re-
corded to see if any radical intermediates could be detected in the 
reaction. 0 ~3 III -2 A solution of 2. x 10 M cyt c and 1.0 x 10 MI in 
0.10 M phosphate buffer, pH 7.4, was mixed in a serum bottle and kept 
anaerobic. Aliquots were transferred to an ear tube and frozen in 
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liquid N2 at 1 min and 5 min after mixing. The esr spectra of these 
samples were recorded at liquid N2 temperature (77° K). Room temperature 
spectra were recorded in a flat quartz cell (Varian Associates). The 
III 
cyt c - complex I solution was added to the deaerated cell, sealed 
with a rubber septum and the ear spectrum recorded periodically through-
out the reaction. 
All esr spectra were recorded on a Varian V-4500 spectrometer. 
Treatment of Data 
Determination of rate constants 
The preliminary data obtained for the reduction of cyt c 111 by I 
indicated the reaction was zero order in I and probably first order in 
III 
cyt C III A first order dependence on cyt c yields the following 
rate expression: 
d [ C rr _1 cyt _ 
dt 
III 
=kb Jcyt c ] 
0 S 
[ III] i i l [ cIII] [ IIJ Since cyt c at any g vent me is equa to cyt - cyt c , 
0 
integration of this rate expression gives: 
III 








] = (Af - A)/(£ d - £ ) and [cyt c 11 ] = (A - A)/ 
o o re ox o 
(£ - £ ) , where A is absorbance at any given time, Af is final red ox 
absorbance, A is initial absorbance and£ d and£ are the extinction 
o re ox 
coefficients for the reduced and oxidized species, respectively, this 
expression becomes: 
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where C' contains the term ln(£ d - £ ). A plot of ln(Af - A) vs t re ox 
III 
should be linear for a reaction which is first order in cyt c and 
zero order in reductant (or under pseudo first order conditions in a 
reaction which is first order in reductant and the reductant is in a 
large excess). The slope of such a plot yields the observed first order 
rate constant directly. 
The first order plots for the reduction of cyt cIII by I deviated 
from linearity after about 2 half-lives, so the first order rate con-
stants were determined from the linear portion of the plots. The ob-
served autocatalytic effect is probably due to the production of cysteine, 
III 
which also reduces cyt c 
III 
The reduction of cyt c by II was found to be second order, first 
order in each reactant. Since II is a two electron reductant and cyt 
cIII is a one electron oxidant, the stoichiometry of the reaction must 
be accounted for in the rate expression, although the rate has a first 
order dependence on both reactants: 
d[ cII] III 
cyt - = k[cyt c ]III] 
dt 
II Letting [cyt c ] = X, this expression becomes: 
dX III 




- 1/2 X) 
Integration of this rate expression gives: 
1 
{II] - [cyt cIII] /2 
0 0 
ln 
( [ II ] - 1 / 2 X) 
0 
([cyt cIII] ~ X) 
0 
= k b t + C 
0 S 
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A plot of the left side of this integrated expression vs t should be 
linear for a second order reaction and the observed second order rate 
constant is obtained directly from the slope. The rate constants for 
second order reactions were determined from an appropriate least squares 
program on a PDP-8 computer. The second order plots for such reactions 
were generally linear for greater than 3 half-lives, with standard 
deviations generally less than 10%. 
In cases where the reaction was biphasic (e.g. with formyl-cyt 
III 
c ), rate constants for the initial phase were determined by the 
Guggenheim method (129). According to this method the following re-
lationship holds: 
where At is absorbance at time t, At+~t is absorbance at some increment 
of time, ~t, later and k is the first order rate constant. Using a con-
stant increment of time, ~t, for a given run and plotting the left side 
of this expression against (t - t) should produce a straight line with 
0 
slope k. One drawback with this method is the large standard deviations 
obtained in the plots. This is due to the limited accuracy in measur-
ing absorbance and the rather small differences in A and At which 
t+~t 
tend to magnify the errors. First order or pseudo first order con-
ditions prevailed when this method was employed. 
III 
The reduction of Im-cyt c by II is complex and, on first inspec-
tion, appeared to be biphasic. A very rapid phase, the amount of which 
depended on the concentration of II, was found to be best explained as 
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d f I III b () a re uction o m-cyt c y Mo V monomer. The concentration of 
i t db th f i f I III d d . h monomer was est ma e y e ract on o m-cyt c re uce int e 
fast phase and an equilibrium constant determined for the reaction: 
K 
II 4 2 Mo(V)-L (monomer) 
The values for the equilibrium constant determined in this way, is 
estimated at 4 x 10-
7 
M. Since the Mo(V) monomer is a one electron 
reductant, the second order rate expression for the reaction of Mo(V) 
III 
monomer with cyt c is: 





h [ II] were X = cyt c , and integration gives: 
1 
[Mo(V)] - !cyt cIIIJ 
0 0 
(!Mo (V) J - X) 
ln -----" 0'----
([cyt cIIIJ - X) 
0 
=kt+ C 
A plot of the left side of this expression vs t should be linear and 
the slope= kb. A least squares treatment of the data, where 
0 S 
III 
[Mo(V)] > [cyt c ] , gave linear second order plots with standard 
0 0 
deviations generally less than 10%. The second order rate constants 
could only be determined for cases where 
since at lower initial concentrations of 
III 
JMo(V)] > {Im-cyt c ] , 
0 . 0 
Mo(V) monomer, other reactions 
interferred and resulted in nonlinear plots. 
h h i d f h d i f I III b l Te mec an sm propose or t ere uct on o m-cyt c y comp ex 
II yields a very complicated rate law which is not readily integrable. 
The mechanism could, however, be tested, using a computer program which 
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generates simulated data for the overall mechanism. The computer method, 
developed by Moore and coworkers (130,131), is based on the fact that 
each chemical component has a time dependent rate expression (the first 
derivative) for its appearance and disappearance, which can be differen-
tiated again. The second derivative of this component can be expressed 
in terms of the first derivatives and concentrations of the other in-
volved components. This operation can be performed for all of the chemi-
cal species involved in the mechanism. Since the first and higher 
derivatives for each component can be obtained, a Taylor Series expan-
sion can be used, which gives the time dependent concentration of each 
component as a function of the differential expressions and concentra-
tions of the other involved components. A convergence test can be built 
into the program to determine a suitable time increment, and the series 
inherently conserves mass. The accuracy of the numerical solution is 
related to the stringency of the convergence test. 
Each step of the chemical .mechanism must be fed into the computer 
program, along with the rate constants for each step and the initial 
concentration of each species involved. The computer printout gives 
the concentration of each component for any time interval desired. 
Comparison of the computer simulated data with the experimentally ob-
served data should indicate the accuracy of the proposed mechanism. 
The main disadvantage of this approach is that all of the rate constants 
and the initial concentrations of all species must be known and the 
accuracy of the method is strongly dependent on the accuracy of the 




Reduction of Cyt c by Complex I 
III 
Complex I reduces cyt c very slowly; the reduction is very 
interesting, however, in that the rate of reduction is independent of 
the concentration of I over a very wide concentration range (Table 4). 
The rate was found to be first order in cyt cIII and followed a first 
order equation, except for an autocatalytic effect observed beyond one 
half-life, which is probably due to the production of cysteine which 
III 
also reacts with cyt c Table 6 shows the observed rate constants 
III 
(kb) for the reduction of cyt c by I in phosphate buffer; the 
0 S 
mean value fork b in 0.10 M phosphate buffer, pH 7.5, µ = 0.50, at 
0 S 
20.0° C is 1.09(±0.10) x 10- 3 -1 sec Similar rate constants were ob-
tained when the disappearance in absorbance at 695 nm was followed 
(Table 6). The first order plots are shown in Figure 6. 
III The effect of pH on the reduction of cyt c by I is shown in 
Table 7. The value of kb increased approximately two fold in going 
0 S 
from pH 6.0 to 7.5, but increased by a factor of about 2.5 between pH 
7.5 and 8.0 (Table 8). Such a large increase in the rate constant be-
tween pH 7.5 and 8.0 can be attributed to the formation of complex II, 
which results from the equilibrium between I and II in basic solution 
(pH >7.5) (19). At pH >8.0 the rate increased even more and deviated 
significantly from first order. 
Table 4. Reduction of cyt c
111 
by complex I in 0,10 M phosphate buffer, pH 7.5, µ = 0.50 with NaCl, 
20.0° c, [cyt cIII]o = 3.35-3.78 x 10-5 M. fI]o: (1) 2.00 x 10-5 M; (2) 4.00 x 10-5 M; 
(3) 8,00 X 10- 5 M; (4) 1.60 X 10-4 M; (5) 4.00 x 10-4 M; (6) 8.00 x 10-4 M; (7) 2.00 x 
10-3 M; (8) 4.00 x 10-3 M; (9) 4.00 x 10-4 M; (10) 8.00 x 10-4 M; (11) 2.00 x 10-4 M; 
(12) 8.00 x 10-4 M. ~ 0.28 M phosphate buffer, pH 7.5, µ = 0.74, .£ 0.01 M phosphate 
buffer, pH 7.5, µ = 0.50 with NaCl. 
Absorbance {550 nm2 
t(sec2 1 2 3 4 5 6 7 8 9a 10a llb 12b 
0 .338 .355 .350 .350 .334 .363 .330 .355 .373 .349 .350 .365 
100 .393 .388 .405 ,415 .404 .419 .400 ,388 .436 .406 .420 .431 
200 .446 .426 .456 .469 .459 ,467 .461 .426 .487 ,456 .480 .471 
300 .497 .473 .504 .520 .507 .510 .514 .473 .532 .505 .540 .547 
400 .548 ,515 .548 .565 .550 .550 .561 .515 • 57,5 . 550 .593 . 600 
500 .593 .555 ._590 .610 .590 .587 .604 ,555 .616 .595 .641 .648 
600 .634 .592 .630 . 644 .627 .624 .642 .592 .654 . 636 .685 .691 
800 .710 ,659 ,699 .708 .693 ,689 .708 .659 • 723 .710 . 760 .767 
1000 • 774 ,714 .759 .765 .747 .746 .760 . 714 .781 • 773 .820 .826 
1200 .825 .760 .810 ,808 .791 . 797 .800 .760 .830 .825 • 864 .875 
1400 .870 .796 .855 .845 .828 .840 .838 .796 .870 • 867 .898 . 911 
1600 .905 ,824 .890 • 87 5 .856 .879 .858 .824 • 900 .900 • 920 . 939 . 
1800 .932 .846 .920 .897 .878 .910 .875 .846 .923 .926 .937 .959 
Af 1.026 .923 1.026 .957 ,9.30 1.042 .935 .923 .965 .980 .980 1.028 
Table 5. 
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III Rate constants for the reduction of cyt cIII by complex I 
with varying concentrations of I. [cyt c )
0 
= 3.35-3.78 
x 10-5 M, µ = 0.50 adjusted with NaCl, pH 7.5, 20.0° C. 
aµ= 0.74, J:?. rate constants obtained from the . decrease in 
absorbance at 695 nm, conditions were as described in 
Table 6. k m 1.09 (± 0.10) x 10-3 sec-1, av 
{I] !phos] k 0 obs 
(M x 10 4) (M) (sec -1 X 10 3 ) 
0.200 0.10 0.87 
0.400 0.10 1.02 
0.800 0.10 1.05 
1.60 0.10 1.15 
4.00 0.10 1.18 
8.00 0.10 0.99 
20.0 0.10 1.02 
40.0 0.10 1.09 
4.00 o.2aa 1.17 
8.00 0.28 8 1.12 
2.00 0.01 1.27 
8.00 0.01 1.13 
4.oob 0.10 1.06 
20.0h 0.10 1.02 
40, ob 0.10 1.09 
Table 6. Reduction of cyt c
111 
by complex I following absorbance at 
695 nm in 0.10 M phosphate buffer, pH 7.5, µ = 0.50 with 
NaCl, at 20.0° C, [cyt cIII] = 1.75-1.95 x 10-4 M. (1) 
[1]8 = 4.00 X 10- 4 M; (2) [IJo = 2.00 X 10-3 M; (3) [I]o = 
4.0 x 10-3 M. 
Absorbance (695 run) 
t(sec) 1 2 3 
0 .147 .161 .142 
100 .138 .153 .132 
200 .130 .145 .123 
300 .122 .138 .116 
400 .114 .134 .108 
500 .107 .125 .102 
600 .100 .118 .095 
800 .088 .107 .084 
1000 . 079 .097 .075 
1200 .071 .088 .067 
1400 .064 .082 .061 
1600 .059 .076 .056 
1800 .055 .071 .052 
550nm 695nm 
-3 --I 
kobs = 1.11 X 16\ec-1 -o. kobs= 1.15 X 10 sec 
-1.0 -3.0 -C -
~-1.5 f-3.5 
C ~ -C ---2. Ji -4.0 
• 
-2.5 • -4. • 
-3. • -5.0 
4 8 12 .16 4 8 12 16 
t (NC X 10-', t (aec X 10-e, 
Figure 6, First order plots for the reduction of cyt c111 by complex I, Reduction of cyt c111 was 
monitored by increase in absorbance at 550 nm (left) or decrease in absorbance at 695 nm 
(right). 
• 
Table 7. Effect of pH on the reduction of cyt c
111 
by complex I in 0.10 M phosphate buffer, JJ = 0.50 
adjusted with NaCl, 20.0° C, Jcyt cIIIJ 0 = 3.26-3.71 x 10-5 M. (1) II] 0 = 4.00 x 10-4 M; 
(2) [I]
0 
= 8.00 x 10-4 M. 
Absorbance (550 nm) 
EH 6.0 EH 6.4 pH 6.0 EH 7. 5 EH 8.0 
t(sec) 1 2 1 2 1 2 1 2 1 2 
0 .338 .340 .360 .370 .340 .358 .334 .363 .323 .328 
100 .375 .411 .425 .459 .387 .418 .404 .419 .456 .445 
200 .400 .448 .464 .515 .421 .463 .459 .467 .556 .538 
300 .424 .478 .498 .562 .450 .504 .507 .510 .635 .613 
400 .448 .505 ,528 .604 .479 .542 .550 .550 • 697 • 673 
500 .470 .529 .556 • 642 .506 • 577 .590 .587 • 745 • 722 
600 .492 .550 .584 .675 .531 .610 • 627 .624 • 784 .762 
800 • 532 .592 .635 .735 .578 .670 • 693 .689 ,834 .818 
1000 • 570 .628 .680 .783 .621 .720 .747 .746 .862 .851 
1200 .604 . 661 .720 .823 • 660 .764 .792 .797 .876 .870 
1400 ,637 .690 ,758 .857 .696 .800 .828 .840 .884 ,878 
1600 .667 .718 .790 .884 • 728 .832 .856 .879 ,883 
1800 . 695 • 743 .821 .906 • 7 57 .858 .878 .910 
2400 .768 .804 .894 . 946 .825 • 911 
3000 .825 .850 • 943 .9-60 .874 .937 
3600 .870 .883 . 973 .964 .907 • 949 
Af . 977 .987 1.023 . 973 .955 • 962 .930 1,042 • 900 .898 
Table 8. Effect of pH on the rate constants for the reduction of 
cyt cIII by complex I. 0.10 M phosphate buffer,µ= 0.50 
adjusted with NaCl, 20.0° C, lcyt cIIIJ
0 




































The rate also increased with increasing temperature over the temper-
ature range studied (Table 9). Table 10 shows the effect of temperature 
on kb : at temperatures above ca. 35° C, the rate decreases and the re-o s 
action becomes complex, probably due to heat denaturation of the protein. 
Activation parameters were calculated from an Eyring plot, 
ln(k b /T) vs 1/T (Figure 7), of the data in Table 10, using a least 0 S 
squares program for the best fit of the data. The enthalpy of activation, 
lilit, is 22.8(±2.8) kcal/mol and the entropy of activation, ~St, is +6.8 
(±6. 2) eu. 
III 
Such a zero order dependence on complex I in the reduction of cyt 
c suggests a possible mechanism involving an initial rapid complex 
III 
formation between cyt c and I and a subsequent slow electron transfer 
(see discussion). To test such a mechanism, an attempt was made to 
Table 9. Effect of temperature on the reduction of cyt c III by complex I. 0.10 M phosphate buffer, 
pH 7.5, µ = 0.50 with NaCl, [cyt cIII]
0 
= 3.44-3.92 x 10-5 M; 11] 0 = 8.00 x 10- 4 M. 
Absorbance (550 run) 
t(sec) 10.0° C 15.2° C 20.0° C 25.0° C 30.0° C 
0 .338 .360 .402 .334 .365 .370 .360 .367 .387 .372 .375 .385 
50 ... .371 .405 .402 .459 .452 .460 .480 .481 .533 
100 .365 .435 .502 .404 .440 .433 . 541 .525 .525 • 574 .574 • 645 
150 .433 .474 .462 .610 .591 .584 .654 .651 .733 
200 .385 .492 • 572 .459 .504 .490 .668 .647 .636 .720 • 716 • 798 
250 ... .718 .695 .685 . 775 .769 .845 
300 .403 .541 .632 .507 .559 .544 • 7 58 .738 .729 .820 .813 .880 
400 .421 .586 .685 .550 .609 .592 .820 • 807 .803 .885 .878 .922 
500 .439 .627 .732 .590 .654 .638 .864 .858 .864 .928 .920 .944 
600 .459 .665 . 778 .627 .696 .680 .892 .895 .912 .953 .947 • 951 
700 . 969 .962 
800 .493 .730 .855 .693 .766 . 754 .922 • 942 .980 
1000 .526 .786 . 916 .747 .821 .815 .934 .964 1.020 
1200 .557 .830 .961 .792 • 863 .865 . 973 1.044 
1400 .589 .865 1.000 .828 .893 .902 
1600 .619 .893 1.029 .856 .913 .930 
1800 .649 .915 1.050 .878 . 930 .951 
2400 . 725 
3000 .791 
3600 .844 
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Eyring plot for the reduction of cyt c by complex I. 
Conditions are as described in Table 10. ~Ht= 22.8 
(±2.8) kcal/mol, ~st= 6.8 (±6.2) eu. 
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Table 10. Effect of temperature on the rate constants for the reduction 
of cyt c 1II by com!lex I. 0.10 M phosphate buffer, pH 7.5, 
µ = 0.50, [cyt ell 10 = 3.44-3.92 x 10-5 M, [Il 0 = 8.00 x 
10- 4 M. 








detect such a cyt c -I complex. Electronic absorption spectra, re-
corded innnediately after mixing the two reactants, showed no difference 
in absorption in the visible or near ultraviolet regions of the spectrum. 
III 
Addition of cyt c to a solution of complex I caused no immediate 
shift in the polarographic reduction potential of complex I. Further-
II 
more, there was no evidence of complex formation between cyt c and I 
by either spectral or polarographic techniques. 
Attempts were also made to show complex formation between complex I 
and either oxidized or reduced cyt c by chromatography on Sephadex G-25 
gel columns. Mixing the two reactants together and chromatographing 
the mixture immediately on a Sephadex G-25 column gave no evidence for 
binding. The Hummel-Dryer method (see methods section) for determining 
ligand binding to proteins also gave negative results. 
In order to obtain evidence for possible intermediates in the re-
action, esr spectra were recorded at room temperature and liquid N
2 
temperature at various times during the reaction. No evidence for 
72 
appreciable amounts of esr active Mo(V) monomer was obtained. This is 
not surprising since the Mo(V) monomer would probably be much more re-
active than complex I and would therefore not accumulate. Cyt 
III 
C 
shows no appreciable esr absorption under these conditions due to un-
favorable characteristics of its spin lattice relaxation (132) and 
III 
signals are only observed for cyt c at very low temperatures (liquid 
He temperatures). 
Schejter and Margalit (133) found that chloride and phosphate ions 
III have a significant effect on the thermodynamic properties of cyt c • 
Tris-cacodylate buffer was used in that study as a nonbinding medium for 
comparison. The nonbinding medium caused a decrease in the observed 
redox potential with increasing ionic strength, whereas a binding medium 
(chloride) caused an increase in the observed redox potential with in-
creasing ionic strength. Increasing the concentration of chloride in 
the nonbinding medium at constant ionic strength caused a decrease in 
the observed redox potential, thus favoring the oxidized form of cyt c. 
Other buffer systems were used in this study to determine what 
effect phosphate may have on the kinetic properties of the reaction be-
III 
tween cyt c and complex I (see Tables 11-15 for data). Table 16 gives 
III the observed rate constants for the reduction of cyt c by I in 10 mM 
phosphate buffer, 20 mM tris-cacodylate buffer, 10 mM HEPES (N-2-
hydroxyethylpiperazine-N'-2-ethanesulfonic acid) buffer, and 10 mM HEPES 
buffer with 10 mM NaCl added. The observed first order rate constants 
increase with increasing concentration of I in phosphate and HEPES 
buffers, but are affected very little by the concentration of I in 
-3 -1 tris-cacodylate buffer (k • 9.6(±1.0) x 10 sec ). The first order 
Table 11. Reduction of cyt cIII by complex I in 10 mM phosphate buffer, pH 7.5, µ = 0.026, 
T = 20.0° C, [cyt cIII1 0 = 1.80-1.85 x 10-5 M. (1) [Il 0 = 1.10 x 10-5 M; 
(2) [I] 0 = 2.20 x 10-
5 M· (3) [Il 0 = 4.40 x 10-5 M· (4) [Il 0 = 8,80 x 10- 5 
M; (5) [110 = 2.20 x 10-4 M; (6) [Il 0 = 4.40 x 10-4 M; (7) [Il 0 = 1.10 x 10-3 M. 
Absorbance {550 nm2 
t(sec 1 2 3 4 5 6 7 
0 .165 .170 .180 .182 .185 .200 .225 
10 .207 .214 .236 ,276 
20 .228 .236 .262 .305 
30 .248 . 257 .287 .330 
40 .268 .278 ,308 ,352 
50 .228 .253 .270 
60 .304 .315 .348 .389 
80 .337 .348 .381 .419 
100 .278 .322 .347 .365 . 377 .408 .443 
120 .390 .402 .430 .462 
140 .412 .423 .449 .478 
150 .320 .376 .403 
160 .435 .440 • 463 .489 
180 .445 .455 .475 .499 
200 .355 .416 .442 
250 .383 .446 .468 
300 .406 .466 .482 
350 .425 .477 .490 
400 .439 .484 .494 
500 .460 .490 
600 .473 
Af .495 .495 .500 .500 .500 .510 . 528 
--..J 
w 
III Table 12. Reduction of cyt c by complex I in 20 rnM tris-cacodylate buffer, pH 7.0, µ = 0.018, at 
20.0° C, [cyt cII 1]0 = 3.75-3.80 x 10- 5 M. [I] : (1) 2.00 x 10-5 M; (2) 4.00 x 10-5 M; 
(3) 6.00 x 10-5 M; (4) 8.00 x 10-5 M; (5) 1.00 ~ 10-4 M; (6) 2.00 x 10-4 M; (7) 5.00 x 10-4 M; 
(8) 1.00 x 10- 3 M; (9) 2.00 x 10-3 M. 
Absorbance (550 nm) 
t (sec) 1 2 3 4 5 6 7 8 9 
0 .363 .375 .368 .365 .365 .368 .380 .390 .430 
10 .435 .430 .428 .423 .428 .424 .435 .450 .486 
20 .494 .488 .488 .480 .488 .464 .482 .497 .538 
30 .552 .543 .543 . 535 . 543 .522 .525 • 540 .575 
40 .608 .600 .597 .585 .595 .565 .566 . 579 . 616 
60 .707 . 700 .692 . 677 .685 .644 • 640 . 650 .688 
80 .785 .784 . 772 .755 . 761 .712 .702 .712 .751 
100 .847 .850 .836 .818 .822 .767 . 755 .765 .806 
120 .815 .800 .812 .855 
140 .932 . 943 .925 . 908 .908 .855 .840 .850 .895 
160 .888 .872 .885 . 930 
180 . 984 . 994 . 978 .961 .962 .915 .900 .912 .960 
Af 1.038 1.038 1.038 1.038 1.038 1.040 1.043 1.045 1.090 
Table 13. . III . Reduction of cyt c by complex I in 10 mM HEPES buffer, pH 7.5, µ = 0.0050, at 20,0° C, 
[cyt cllI] 0 = 3.64-3.70 x 10- 5 M. [I] 0 : (1) 2.00 x 10- 5 M; (2) 5.00 x 10-5 M; (3) 1.00 x 
10-4 M; (4) 2,00 x 10-4 M; (5) 5.00 x l0-4 M; (6) 1.00 x 10-3 M; (7) 2.00 x 10-3 M. 
Absorbance (550 nm2 
t(sec2 1 2 3 4 5 6 7 
0 .344 .347 .340 .345 .360 .388 .460 25 .388 .425 .415 .458 .468 .480 .560 50 .430 .501 .494 .558 .560 .560 • 640 75 .470 .569 .560 .643 .638 .627 .708 100 .507 .629 .623 . 712 .704 .685 .763 125 .683 • 677 . 772 .760 .735 .810 150 .574 .730 • 725 .822 .806 .780 .852 175 • 774 . 772 .863 .847 .818 .885 200 . 636 .813 .810 .897 .880 .852 .915 250 .693 .878 .875 .947 .930 .904 .960 300 .744 .930 .925 .977 .965 .946 .990 350 .792 .967 .960 .992 .985 • 97 5 1.0ll 400 . 835 .988 • 983 .997 .998 . 998 1.024 500 .907 
600 .958 
Af 1.020 1.012 1.012 1(004 1.010 1.036 1.047 
76 
Table 14. Reduction of cyt c
111 
by complex I in 10 mM HEPES buffer, 
pH 7.5, µ = 0.0050, at 20.0° C, Icyt cIII] 0 = 1.92-1.98 x 
10-5 M. [1)
0 
: (1) 1.0 x 10-5 M; (2) 2.00 x 10-5 M; 
(3) 5.00 x 10-5 M; (4) 1.00 x l0-4 M. 
Absorbance (550 nm) 
t (sec) 1 2 3 4 
0 .165 .190 .195 .205 
10 .229 .250 .261 . 272 
20 .262 .292 .312 .329 
40 .316 .358 .391 .415 
60 .359 .409 .447 .472 
80 .394 .448 .486 .508 
100 .423 .479 . 512 .529 
120 .537 
140 .468 .518 .534 
180 .500 .532 
Af .530 .538 .544 .548 
Table 15. Reduction of cyt c
111 
by complex I in 10 mM HEPES buffer, 
pH 7.5, µ = 0.015, at 20.0° CS [cyt clll] 0 = 1.90-2.00 x 
10-5 M. [1]
0 
: (1) 1.00 x 10- M; (2) 2.00 x 10-5 M; 














































































III Observed rate constants for the reduction of cyt c by 
complex I in different buffers. a. 10 mM phosphate 
buffer, pH 7.6, µ = 0.026, [cyt cTII] = 1.80 x 10- 5 M; 
E.· 20 mM tris-cacodylate buffer, pH ~.O, µ = 0.018, 
[cyt cIII] 0 = 3.76 x 10-5 M; c. 10 mM HEPES buffer, pH 
7.5, µ = 0.0050, [cyt cIII] 0 =-1.95 x 10-5 M; d. 10 mM 
HEPES buffer, pH 7.5, µ = 0.0050, [cyt cIII] 0 -= 3.70 x 
10-5 M; e. 10 mM HEPES buffer, 10 mM NaCl, pH 7.5, 





































plots at such low ionic strength indicate the reaction is much more 
autocatalytic (a positive deviation in the first order plot) than at 
III higher ionic strength, probably due to a faster reduction of cyt c 
by cysteine (released in the reaction) at these lower ionic strengths. 
The rate constants observed in HEPES buffer are interesting; by 
III increasing the initial concentration of cyt c , the rate constant de-
creases. This was very puzzling at first, but considering the cyt cIII 
has a net charge of 7 or 8+ at this pH, and the ionic strength of the 
III HEPES buffer is only 5 mM, the concentration of cyt c would affect 
78 
the ionic strength of the medium significantly; therefore, 10 mM NaCl 
was added to the HEPES buffer to see how drastic the ionic effect would 
be. It is apparent the ionic effect is quite strong under these con-
ditions; addition of 10 mM NaCl caused a >50% decrease in the observed 
rate constants (Table 16). The slight decrease in rate with increasing 
concentration of I in tris-cacodylate buffer, although hardly beyond the 
limits of experimental error, may also be due to an ionic strength 
effect. 
III Reduction of Cyt c by Complex II 
III 
Complex II reduces cyt c very rapidly, several orders of magni-
tude faster than does complex I. The rate of reduction is in fact of 
III the same order of magnitude as the enzymatic reduction of cyt c by 
II NADH-cytochrome c reductase (cyt c
1 
) (78), and is the most rapid rate 
reported for the reduction of cyt cIII by a transition metal complex. 
The reduction by complex II also differs from the reduction by complex 
I in that the rate is first order in both reactants. Representative 
oscilloscope tracings from the stopped flow data are shown in Figure 8 
and Tables 17 and 18 have the absorbance data tabulated for dependence 
on concentration of II and temperature dependence, respectively. 
III Typical second order plots for the reduction of cyt c by complex 
II are shown in Figure 9 and the observed second order rate constants 
for the reaction are given in Table 19. It is necessary to set a lower 
limit on the concentration of II (ca. 5 x 10- 6 M) due to oxidation of II 
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Figure 8. Oscilloscope tracings for the reduction of cyt cIII by 
complex II. Experimental conditions were: 0.20 M phos-
phate buffer, pH 7.0, µ = 0.40, 25.0° C, [cyt cIII] 0 = 6 1.00 x 10-5 M~ [II] 0 : (a) 3.00 x 10- 6 M; (b) 6.70 x 10-
M; (c) 9.00 x 10-6 M; (d) 1.90 x 10-5 M. 
Table 17. Reduction of cyt cIII by complex II in 0.20 M phosphate buffer, pH 7.0, µ = 0.40, at 20.0° C 
and 25.0° C, [cyt cIII]
0 
= 9.10-9.90 x 10-6 M. [II] : (1) 6.70 x 10-6 M; (2) 9.00 x 10-6 M; 
(3) 1.34 x l0-5 M; (4) 1.90 X 10-5 M; (5) 6.70 x 10_g M; (6) 1.34 X 10-5 M; (7) 3.00 x 10-6 M; 
(8) 6.70 x 10-6 M; (9) 8.00 x 10-6 M; (10) 9.00 x 10-6 M; (11) 1.90 x 10-5 M. ~ µ = 1.35 
with NaCl. 
Absorbance (550 nm) Absorbance (550 run) 
t(msec) 1 2 3 4 t(msec) 5 6 
20.0° C 
0 .085 .085 .085 .085 0 .097 .097 
4 .178 .183 .220 .220 5 .177 
5 . 228 10 .16 7 . 215 
6 .193 .198 .237 .233 15 .233 
8 .205 .211 .250 .245 20 .195 .245 
10 .214 .222 .256 25 .253 
14 .233 30 .210 ---- -7-- - -- _________ 8 _____________________ 9 ___________________ 10 ___________________ 11 __________ _ 
t(msec) A550 t(msec) A550 t(msec) 550 t(msec) A550 t(msec) A550 
0 .085 0 .090 0 .085 0 .085 0 .085 
20 .182 4 .195 4 .200 4 .183 4 .220 
40 .193 6 .210 6 .212 6 .200 5 .228 
60 .196 8 .225 8 .223 8 .212 6 .233 
80 .199 10 .233 10 .233 10 .220 8 .242 
100 .201 12 .240 12 .238 14 .230 





Table 18. Effect of temperature on the reduction 
III 
of cyt c by com¥lex 
II in 0.20 M phosphate buffer, pH 7.0, µ = 0.40, [cyt cII] 
= 0.970-1.02 x 10-5 M, [II] 0 : (1) 6.70 x 10-6 M; (2) 1.34 o 
x l0-5 M. 
Absorbance (550 nm) 
11.0° C 15.0° C 30.0° C 
t (msec) 1 2 1 2 1 2 
0 .120 .120 .095 .095 .093 .093 
4 .220 .208 .185 .234 
5 .190 .175 .240 
6 .237 .223 .200 .248 
8 .249 .196 .238 .212 
10 .217 .258 .207 2.48 .223 
14 .264 .232 
15 .232 .222 
20 .242 .235 .243 
25 .250 .243 .243 
30 .255 
under these conditions the half-life of the reaction is between 1.6 and 
8.4 msec. Since the dead time of the stopped flow instrument is 3 to 4 
msec, the rate constants had to be evaluated from the last 30 to 50% of 
the reaction. The linearity of the second order plots (Figure 9) and 
the agreement of the rate constants for varying concentrations of II 
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Figure 9. Second order plots for the reduction of cyt cIII by complex 
II. 0.20 M phosphate buffer, pH 7.0, µ = 0.40, 20.0° C, 
[cyt cIII] = 9.80 x 10-6 M. [II] = t.34 x 10- 5 M, 
o-[II] = 8.70 x 10-6 M. Cr= [cy~ cI] and Mo and C
0 
are 
the in~tial concentrations of II and cyt cIII, respectively. 
83 
Table 19. Observed rate constants for the reduction of cyt cIII by 
complex II. 0.20 M phosphate buffer, pH 7.0, µ = 0.40, 
[cyt cIII]
0 
= 1.00 x 10-5 M. '*µ = 1.35 with NaCl. 
[II] 
0 
T k obs 
(M X 10 5 ) (OC) (M-1 
-1 -7 
sec x 10 
0.670 11.0 1.61 
1.34 11.0 1.43 
0.670 15.0 1. 91 
1.34 15.0 1.98 
0.670 20.0 2.40 
0.900 20.0 2.00 
1.34 20.0 2.75 
1.90 20.0 2.43 
0.300 25.0 2.63 
0.670 25.0 3.83 
0.800 25.0 2.08 
0. 900 25.0 2.26 
1. 90 25.0 2.10 
0.670 30.0 2.82 
1.34 30.0 2.96 
0.670* 20.0 0.59 
1.34* 20.0 o. 79 
The activation parameters were calculated from a least squares 
program from the Eyring plot (ln(k b /T) vs. 1/T), shown in Figure 10, 
0 S 
of the data in Table 19. The values obtained are: ~Ht= 4.8 (±1.3) 
kcal/mol and ~St= -8.6 (±4.4) eu in 0.20 M phosphate buffer, pH 7.0, 
µ = 0.40. 
The rate decreased very significantly with an increase in ionic 
strength (the last two entries in Table 19), which is expected for two 
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3.60 
III Eyring plot for the reduction of cyt c by complex II. 
Conditions are as described in Table 19. ~Ht= 4.8 
(±1.3) kcal/mol, ~st= -8.6 (±4.4) eu. 
84 
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III Reduction of Ligand Bound Cyt c by Complex II 
Th d · f N III b · h 1 h h d ere uction o 3-cyt c y II is muc sower tan t ere uc-
III 
tion of native cyt c and the rate is independent of the concentration 
of II (Table 20). The observed first order rate constant for the re-
-1 III action is 5.4(±0.2) sec • The rate of reduction of CN-cyt c by II 
(Table 21) is extremely slow and also independent of the concentration 
of II, with an observed first order rate constant of 1.6 x 10- 5 sec- 1 . 
The observed rate constants for these reactions as well as the reduction 
of cyt cIII in the presence of N-acetylmethionine (NAM)(Table 22) are 
given in Table 23. NAM has no significant effect on the rate of reduc-
. f III b d d h h h tion o cyt c y II an is assume to not interact wit t e eme 
iron. It is possible that NAM does bind to the heme iron giving the 
same properties as the native protein; this does not seem likely, how-
ever, since the bulk of the NAM would be expected to produce significant 
conformational changes which would affect the kinetic and thermodynamic 
properties of the cyt c molecule. 




cyt c (Table 23) are nearly identical to the rate constants for dis-
sociation of these ligands from the complex. This strongly suggests 
III that II does not react with these complexes of cyt c , but does react 
III 
very rapidly with the free cyt c produced by ligand dissociation. 
III The observed rate constants for dissociation of N
3
- and CN-cyt c are 
-1 -5 -1 
5.4 sec and 1.3 x 10 sec , respectively (76), in very close agree-

























-cyt cIII by complex II in 0.20 M phosphate 
buffer, 0.25 M NaN3 , pH 7.0, µ = 0.60, 25.0° C, [c!t cIII] 0 (total) = 2.00 x 10-5 M, [N -cyt cIII]
0 
= 1.1 x 10- M. 
[II] 0 : (1) 4.00 x 10-5 M; t2) 8.00 x 10-5 M; (3) 2.00 x 
l0-4 M; (4) 1.00 x 10-3 M. 
1 2 3 4 
.403 .405 .410 .450 
.430 .440 .450 .490 
.460 .462 .480 .510 
.475 .483 .500 .527 
.490 .500 .510 .543 
.500 .508 .522 .555 
.518 .522 .537 .573 
.526 .535 .543 .589 
.540 .550 .558 .593 
III 
Reduction of CN-: 2t c by complex :I in 0.20 M phosphate buffer, 1.1 x 10 M KCN, pH 7.0, µ - 0.40f 25.0° C, (cyt 
cIII] 0 (total)= 1.95 x 10-5 M, [CN-cyt c 1 1 ) 0 = 1.90 x 
10-5 M, [II] 0 = 1.00 x 10-3 M. 
A550 t(sec) A550 
.230 6,250 .430 
.246 7,500 .457 
.268 10,000 .493 
.288 12,500 .518 
.307 15,000 .530 
.324 17,500 .539 
.366 20,000 .543 
.402 Af .547 
Table 22. Reduction of cyt c 11 l by complex II in the presence of 
N-acetylmethionine. 0.10 M phosphate buffer, 0.20 MN-
acetylmethionine, [cyt cIII1
0 
= 9.40 x 10-6 M, (1) [IIl
0 = 9.00 x 10-6 M, (2) [IIl 0 = 1.80 x l0-5 M. 
1 2 
t(msec) A550 t(msec) A550 
0 .105 0 .105 
8 .190 6 .225 
10 .203 8 .234 
15 .217 10 .243 






0.05 M phosphate buffer, 0.30 M N-acetylmethionine, [cyt cIIIl
0 x 10-6 M, (3) [IIl 0 = 9.00 x 10-6 M, (4) [IIl 0 = 1.80 x 10- 5 M. runs at pH 7.0, µ = 0.40, 25.0° C. 
3 4 
t(msec) 
A550 t(msec) A550 
0 .055 0 .055 
5 .130 5 .150 
10 .149 8 .164 
15 .163 10 .173 





d f h . . d III l ( III) i Re uction o t e 1m1 azole-cyt c comp ex Im-cyt c s a 
much more complex reaction. At low concentrations of II (approximately 
equal molar with cyt c
111
) the rate of reduction is nearly zero order 
III in II with a rate very nearly that of dissociation of the Im-cyt c 
complex (kobs ~ 1.9 sec-l for reduction of Im-cyt cIII by II and kd = 
-1 III 
2.4 sec for dissociation of the Im-cyt c complex (76)). 
Table 23. Observed rate constants for the reduction of cyt cIII by 
complex II in the presence of heme ligands. a. 0.20 M 
phosphate buffer, 0.25 M NaN3, pH 7.0, µ = 0.65, giving 
50% ligand bound cyt cIII. The initial rapid reduction 
of free cyt cIII was taken into account in determining 
the rates. b. 0.20 M phosphate buffer, 0.11 M KCN, pH 
7.0, µ = 0.41, giving ca. 98% ligand bound cyt cIII. c. 
0.10 M phosphate buffer, 0.20 M N-acetylmethionine, pH-
7.0, µ = 0.40. d. 0.05 M phosphate buffer, 0.30 MN-
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(sec 25 1.5 X 10_
5 1. 6 X 10 
M-1 -1 sec 
1. 70 X 10~ 
1. 90 X 10 
1. 20 X 10~ 
0.96 X 10 
88 
At higher concentrations of complex II, however, the reaction becomes 
biphasic, with the amount of fast phase being dependent on the concen-
tration of II. At very high concentrations of II (>100 fold excess), the 
reaction becomes monophasic again. First order plots of this single 
phase were not linear and suggested a second order reaction was in 
effect. Figure 11 shows the oscilloscope tracings obtained from the 
stopped flow spectrometer and the complex II concentration dependence 
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Figure 11. Oscilloscope tracings for the reduction of Im-cyt cIII by 
complex II. Experimental conditions were: 0.20 M phos-
phate-0.50 M imidazole buffer, pH 7.0, µ = 0.65, 25.0° C, 
[cyt cIII] (total)= 2.15 x 10-5 M, [Im-cyt cIII] 0 = 
1.88 x 10-g M. Complex II was diluted in the loading 
syringe with 0.20 M phosphate buffer, pH 7.0, µ = 0.65 
(adjusted with NaCl), [II] 0 : (a) 2.50 x 10-5 M; (b) 
5.00 x 10-5 M; (c) 1.00 x 10-4 M; (d) 2.50 x 10-4 M; 
(e) 5.00 X l0-4 M; (f) 1.00 x l0-3 M. 
90 
Since complex II was initially diluted in the loading syringe of 
the stopped flow instrument with pH 7.0 buffer containing imidazole 
(Table 24), it was suspected that imidazole may affect complex II in 
such a way as to cause the rapid reaction taking place. Complex II 
was therefore diluted with pH 7.0 buffer in the absence of imidazole 
(Table 25); however, the rates were identical with the rates observed 
in the presence of imidazole (within experimental error). Complex II 
was also diluted in the loading syringe with 0.04 M borate buffer, pH 
9.8, which again resulted in very similar rates. 
The dependence of the amount of fast phase on the concentration 
of II suggested Mo(V) monomer may be causing the fast phase. The 
amount of Mo(V) monomer in solutions of complex II was therefore esti-




as a standard. The esr spec-
tra were recorded at liquid N
2 
temperature at pH 7.0 and 10.0 and a 
double integration procedure was used to estimate the amount of Mo(V) 
-3 
monomer in a 1.00 x 10 M solution of complex II in either the presence 
or absence of imidazole. The concentration of esr active monomer in 
the presence of imidazole was found to be approximately 2 x 10-S M 
and the concentration of Mo(V) monomer in the absence of imidazole 
-6 
was approximately 5 x 10 M. These results suggest that imidazole 
has an effect on the concentration of monomer in solutions of complex 
II. The estimated equilibrium constants for the equilibrium between 
II and Mo(V) monomer are K -7 = 4 x 10 Min the presence of 0.50 M 
-8 
imidazole and K = 2 x 10 Min the absence of imidazole, with the 
pH having little effect between pH 7.0 and 10.0. 
Table 24. Reduction of Im-cyt cIII by complex II with both cyt cIII and complex II in 0.20 M phosphate 
0.50 M imidazole buffer, pH 7.0, µ = 0.65 prior to mixing. For runs 1-3, T = 25.0° C, 
[cyt cIII]g (total)= 2.12-2.18 x 10-5 M, [Im-cyt cIII[
0 
= 1.85-190 x 10-5 M, [II]
0
: (1) 
5.00 x 10- M; (2) 2.50 x lQ-4 M; (3) 1.00 x l0-3 M. For runs 4-6, T = 20.0° C, [cyt cIII]
0 (total)= 1.96-2.02 x 10-5 M, [Im-cyt cIII]
0 
= 1.73-1.78 x 10-5 M, [II]
0 
(4) 1.00 x 10-4 M; 
(5) 2.00 x 10-4 M; (6) 5.00 x 10-4 M. 
1 2 3 4 5 6 t(msec) A550 t(msec) A550 t(msec) Assa t(msec) Assa t(msec) Assa t(msec) Assa 
10 .265 7 .338 6 .420 5 .270 5 .303 5 .390 
35 .302 10 .360 8 .453 10 .295 10 .332 10 .440 
50 .330 20 .410 10 .485 15 .305 15 .355 15 .480 
100 .363 30 .442 12 .513 20 .317 20 .370 20 .503 
200 .410 40 .460 14 .530 25 .327 25 .385 26 .520 
300 .443 50 .475 16 .545 50 .360 so .415 35 .540 
400 .478 80 .500 18 .560 100 .390 100 .440 50 .545 
500 .500 100 .510 200 .423 150 .460 100 .555 
600 .515 150 .533 300 .450 200 .475 150 .562 
700 .525 200 .553 400 .473 250 .487 250 .575 
800 .537 250 .570 500 .490 300 .501 
600 .503 350 .510 
700 .512 450 .523 
900 .523 
Af .585 Af .590 Af .590 Af .548 Af .548 Af .585 
I.O .... 
Table 25. Reduction of Im-cyt cIII by complex II with cyt cIII in 0.20 M phosphate-0.50 M imidazole 
buffer, pH 7.0, µ = 0.65 and II in 0.20 M phosphate buffer, pH 7.0, µ = 0.65 (adjusted 
with NaCl), T = 25.0° C, [cyt cIII] 0 (total)= 2.10-2.15 x 10-S M, [Im-cyt cIII] 0 
= 1.84-
1.89 x 10-S M. [II]o: (1) 2.50 x 10-s M; (2) 5.00 x 10-s M; (3) 1.00 x 10-4 M; (4) 2.50 x 
10-4 M; (5) 5.00 x 10-4 M; (6) 1.00 x 10-3 M. 
1 2 3 4 5 6 t(msec) A550 t(msec) A550 t(msec) 550 t(msec) Assa t(msec) A550 t(msec) A550 
5 .245 5 .245 10 .278 10 .360 7 .425 6 .445 
25 .282 25 .285 50 .365 20 .410 10 .455 8 .483 
50 .300 50 .312 100 .405 30 .433 20 .520 10 .513 
100 .320 100 .350 200 .465 50 .456 30 .545 12 .530 
200 .360 200 .400 300 .500 100 .495 40 .560 14 .540 
400 .440 300 .440 400 .523 200 .533 50 .566 16 .550 
600 .485 400 .470 500 .545 300 .556 80 .580 
800 .515 500 .492 600 .555 400 .563 
1000 .538 600 .510 700 .562 
1200 .550 700 .525 
1400 .560 800 .535 
Af .587 Af .590 Af .580 Af .590 Af .590 Af .590 
93 
The reduction of Im-cyt cIII by Mo(V) monomer, at concentrations 
of complex II which were large enough to produce sufficient monomer 
III to completely reduce the Im-cyt c complex, was plotted as a second 
-7 order reaction assuming a value of K = 4.0 x 10 M for the equilib-
eq 
rium between complex II and Mo(V) monomer: 
K 
II~ Mo(V) monomer 
A second order plot of the data in Table 26 was quite linear at 2.00 
x 10-
3 
M complex II, as shown in Figure 12, and gave a second order 
rate constant of ca. -1 sec 
A first order plot of the slow phase is linear for the concentra-
tions where the slow phase could be studied (as shown in Figure 13). 
The observed first order rate constants showed little dependence on 
-5 the concentration of II at low concentrations (<5 x 10 M), but showed 
a much more significant dependence at higher concentrations of II 
(Table 28). Such results suggest complex II, as well as Mo(V) monomer, 
III is reacting with Im-cyt c A second order rate constant was esti-
III mated for the reduction of Im-cyt c by II from the following rela-
tionship: 
where kII is the second order rate constant for reduction of Im-cyt 
cIII by II, kobs is the observed first order rate constant and kd is 
III the dissociation rate constant for Im-cyt c , for which a value of 
1.6 sec-l was estimated at the lowest concentrations of II (this 
94 
Table 26. Reduction of Im-cyt c
111 
at high concentrations of complex 
II. [cyt c 111 ] 0 = 1.90 x 10-5 Min 0.20 M phosphate 
buffer, 0.50 M imidazole, pH 7.0, µ = 0.65. Complex II was 
in 0.02 M borate buffer, pH 9.8, prior to mixing. [11]
0
: 
(1) 1.00 x 10-3 M; (2) 2.00 x 10-3 M. 
1 2 
t(msec) A550 t(msec) A550 
0 .240 0 .335 
5 .475 4 .595 
10 .515 6 .617 
15 .530 8 .630 
20 .539 10 .642 
25 .543 14 .655 
35 .550 
Af .580 Af .675 
relationship is only valid for pseudo first order conditions where 
III 
[II]>>[Im-cyt c ]). The estimated second order rate constant for the 
reduction of lm-cyt c
111 
by II is 1.4 x 10 4 M-l sec-l (see Table 28). 
III The reduction of Im-cyt c by complex II was followed at pH 8.1 
(Table 27). At this pH, 95% of the imidazole is in the free base 
form (proton dissociated) and ca. 94% of the cyt c 111 is ligand bound 
(as opposed to ca. 88% ligand bound at pH 7.0 and the same concentration 
of irnidazole). The results were similar; the observed rate constants 
for the slow phase are given in Table 28, with the values for k
11 
(the 
III calculated second order rate constant for the reduction of Im-cyt c 
by II). III It appears that the rate of dissociation of the Im-cyt c 
complex is somewhat slower at this pH, however, and a value of kd = 
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t ( maec) 
Figure 12. Second order plot for the reduction of Im-cyt cIII by 
Mo(V) monomer. 0.20 M phosphate buffer, 0.50 M imidazole, 
pH 7.0, µ = 0.65, [cyt cIIIJ
0 
= 1.90 x 10-5 M, using a 
value of 2.82 x 10-5 M Mo(V) monomer in a 2.00 x 10-3 M 
solution of II. Complex II was in 0.02 M borate buffer, 
pH 9.8, prior to mixing. T = 20.0° C. M and C are the 
initial concentrations of Mo(V) and cyt 8III, rispectively 
and C = [cyt cIIJ. r 
-






0 0.4 OB 
t(sec) 
1.2 1.6 
Figure 13. First order plots for the reduction of Im-cyt cIII by 
complex II. 0.20 M phosphate buffer, 0.50 M imidazole, 
pH 7.0, µ = 0;65, 20.0° C, [cyt cIII]
0 
(total) = 1.98 
x 10-5 M, with 88% imidazole bound. -[II] = 2.50 
x 10- 5 M, 6-[II]o = 5.00 x 10-5 M, o-[II]o ~ 1.00 x 
10-4 M. 
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Table 27. Reduction of Im-cyt c111 bt complex II in 0,20 M phosphate-0.50 M imidazole buffer, pH 8.1. 
µ = 0.60, 20.0° C, [cyt cl 1]
0 
(total)= 1.80-1.90 x 10-S M, [Im-cyt cIII]
0 
= 1.69-1.79 
x 10-5 M. [II) 0 : (1) 2.00 x 10-5 M; (2) 5.00 x 10-5 M; (3) 1.00 x 10-4 M; (4) 2.00 x 
10-4 M; (5) 5.00 x 10-4 M; (6) 1.00 x l0-3 M. 
1 2 3 4 5 6 
t(msec) A550 t(msec) A550 t(msec) A550 t(msec) A550 t(msec) A550 t(msec) A550 
0 .160 0 .160 0 .160 0 .170 0 .205 0 .280 
100 .244 10 .217 5 .235 5 .268 5 .367 5 .478 
200 .280 20 .235 15 . 272 10 .302 10 .423 6 .496 
400 .325 40 .260 25 .298 15 .325 15 .463 8 .523 
600 .363 60 .280 35 .317 20 .345 20 .495 10 .545 
800 ,397 80 .295 45 .325 26 .362 25 .513 12 .563 
1000 .416 100 .302 100 .368 35 ,383 30 .523 14 .581 
1200 .430 200 .342 200 .415 45 .400 35 .530 16 .598 
1400 .440 400 .400 300 .440 100 .443 18 .604 
1800 .458 600 .433 400 .460 150 .463 
800 .455 500 .477 200 .478 
1000 .472 600 .484 250 .488 
1400 .483 800 .497 350 .500 
Af .500 Af ,500 Af .508 Af .517 Af .547 Af .623 
98 
Tnble 28. Rate constants for the slow phase of reduction of Im-cyt 
cIII by complex II in the presence of imidazole. 0.20 M 
phosphate buffer, 0.50 M imidazole. ~- kII is the second 
order rate constant for the reduction of the Im-cyt cIII 
complex by II which was calculated as described in the 
text. b. Conditions are the same as described in Table 
23. c. Conditions are the same as described in Table 24. 
i- Same conditions as.£ except [cyt cIII]
0 
= 2.00 x 10-5 
M, 20.0° C. e. Conditions are the same as described in the 



















































The reduction of Im-cyt cIII by complex II was also studied at 
pH 10 (Table 29). The reaction is a single phase over a wide concen-
tration range at this pH and showed a first order dependence on the 
concentration of II throughout the concentration range studied. The 
observed second order rate constants are shown in Table 30. The second 
4 -1 -1 order rate constant (k = 6.2(±1.1) x 10 M sec ) is very nearly the 
same as the rate constant observed for the reduction of the high pH 
Table 29. Reduction of cyt cIII by complex II in the presence of irnidazole at pH 10.0. 0.10 N borate 
buffer, pH 10.0, µ = 0.50, 25.0° C, [cyt cIII] 0 = 0.950-1.05 x 10-S M. For runs 1-5 [irnidazole] 
= 0.50 M, and for runs 6-12 [irnidazole] = 0.10 M. [II] 0 : (1) 1.00 x 10-5 M; (2) 4.00 x 10-5 M; 
(3) 1.00 x 10-4 M; (4) s.oo x 10-4 M; (5) 1.00 x 10-3 M; (6) 9.oo x 10-6 M; (7) 1.90 x 10-s M; 
(8) 3.60 x 10-S M; (9) 9.00 x 10-5 M; (10) 1.00 x 10-4 M; (11) 5.00 x 10-4 M; (12) 1.00 x 10-3 M. 
1 2 3 4 5 6 --:---:----




































































































































































































































































form of cyt cIII by II (k = 7.2(±.4) x 10 4 M-l sec-l) (134). This sug-


















III Observed rate constants for the reduction of cyt c by 
complex II in the presence of imidazole at pH 10. 0.10 M 
borate buffer, pH 10.0, µ = 0.50, 25.0° C, [cyt cIII]
0 
= 
0.950-1.05 x 10-5 M. a. 0.50 M imidazole; b. 0.10 M 





















k b / [II] 
0 S 0 
-1 -1 -4 







III III Since complex II reduces Im-cyt c but not N
3
- or CN-cyt c 
it was necessary to determine whether this observation was due to the 
thermodynamics of the reaction between II and these ligand bound cyt 
III 
c species or whether the inability of II to reduce N
3




is a kinetic effect. The redox potentials of complex II and 
ligand bound cyt cIII were therefore determined. 
The experimental potentiometric titration curve for the oxidative 
titration of complex II by thionine is shown in Figure 14. According 
to the Nernst equation: 




where [ox]= concentration of oxidized species of a redox couple and 
[red] = concentration of reduced species of that couple. A plot of 
E vs log ([ox]/[red]) should produce a straight line with a slope of 
.059/n for a reversible process. The plot of E vs log([ox]/[red]) is 
shown in Figure 15 and it is obvious that the oxidation of II by 
thionine is not a reversible process. The midpoint potentials obtained 
from the oxidative titration curves for complex II with various oxi-
dants are given in Table 31. The mean value obtained for the midpoint 
p·otential of complex II is -153 ± 16 mV. 
III The potentiometric titration of native cyt c in phosphate buffer, 
with ascorbate as reductant, gave a midpoint potential at pH 7.0 of 
+251 mV, in excellent agreement with the published value of E' = +254 
0 
mV (135). II Back titration of the cyt c -ascorbate solution with 
K3Fe(CN) 6 as oxidant gave a midpoint potential of +235 mV. 
Th · · · i f III · h f 0 50 M e potent1ometr1c titrat on o cyt c int e presence o . 
imidazole or 0.50 M NaN3 at pH 7.0 was accomplished using electro-




as oxidant; the 
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Figure 14. The experimental potentiometric titration curve for the 
oxidative titration of complex II by thionine. E vs 
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· Figure 15. Potentiornetric titration curve for the oxidative titration 
of complex II by thionine. E vs NHE. 
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Table 31. Midpoint potentials for the oxidative titration of complex 
II. E 8 0 is the midpoint potential at pH 8.0 vs the 
standa~a·nydrogen electrode. 
Oxidant E m8.0 
(mV) 







Average -135 ± 16 
imidazole and azide, respectively. The midpoint potential for the re-
III III 
ductive titration of Im-cyt c is +151 ± 8 mV and of N
3
-cyt c is 
183 ± 5 mV. The midpoint potentials for the oxidative titration of both 
species were about 10 mV more megative. The plot of E vs log([ox]/ 
[red]) for Im-cyt c is shown in Figure 18 and for N
3
-cyt c is shown in 
Figure 19. The nonlinearity of these plots and the large deviation of 
the slopes from the theoretical value of 0.059 (for a one electron pro-
cess) indicate these two redox processes are irreversible, which is not 
II 
unexpected, since neither imidazole nor azide bind to cyt c . 
The thermodynamic midpoint potentials were calculated for the Im-
and N
3
-cyt c couples using equilibrium constants for ligand binding. 
Using the Nernst equation and the follo _wing equations: 
[cyt CIII] (total) - [cyt c 111 ] + [X-cyt CIII] . 
and 
III [X-cyt c ] 
200 ( b) 
100 
(0) 
0.4 0.5 0.6 0.7 OB 0.9 
ml titrant 
Figure 16. The experimental potentiometric titration curve for the oxidative and reductive titrations 
of Im-cyt c. (a) Reductive titration with phthiocol as reductant. (b) Oxidative titration 
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Figure 17. The experimental potentiometric titration curves for the oxidative and reductive titrations 
of N3-cyt c. (a) Reductive titration with phthiocol as reductant. (b) Oxidative titration 
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Figure 18. Potentiometric titration curve for the oxidative and 
reductive titration of Im-cyt c, Data taken from 
Figure 16. -Reductive titration, a-oxidative titration. 
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Figure 19. Potentiornetric titration curves for the oxidative and 
reductive titration of N3-cyt c. Data taken from Figure 17. -reductive titration, a-oxidative titration. 
E vs NHE. 
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III III where Xis ligand and X-cyt c is ligand bound cyt c , one obtains 
the relationship 
E = E0 - .059 log(l + K (X]) 
eq 
at the midpoint (E
0 
is the standard midpoint potential of native cyt c). 
The thermodynamic midpoint potentials of Im-cyt c and N
3
-cyt c, calcu-
lated from this expression are +198 mV and +224 mV, respectively. 
The large differences in the observed and calculated values for 
the midpoint potentials, as well as the indication of nonreversibility 
in the potentiometric titration curve suggests that ligand binding 
causes significant alterations in the cytochrome c molecule, which will 
be discussed later. 
Reduction of PLP Modified Cyt III C 
III The reduction of both PLP
1
-cyt c and L III b l P P2-cyt c y comp ex 
I are similar to the reduction of native cyt III c by that complex. 
The data are shown in Tables 32 and 33. The rate is zero order in I 
III 
and first order in cyt c • The first order plots (ln(Af - A) vs t) 
deviate slightly beyond one half-life, similar to the results with 
III 
native cyt c as shown in Figure 20. Table 34 gives the observed 
first order rate constants for the reaction. The mean value fork b 
0 S 
for the reduction of PLP
1
-cyt III is 7.07 (±1.20) X 10- 4 -1 and C sec 
for the reduction of PLP -cyt III is 10.0 (±2.6) X 10- 4 -1 The C sec . 2 
observed rate constant for reduction of native cyt cIII under similar 
conditions is 7.3 x 10- 4 sec-l It is obvious the introduction of PLP 
groups has little effect on the rate of reduction by complex I, and 
furthermore, has no apparent effect on the mechanism. 
110 
Table 32. Reduction of PLP
2
-cyt c 111 by complex I in 0.10 M phosphate 
buffer, pH 7.0, µ = 0.50, T = 20.0° C, [PLP -cyt cIII] 0 = 
5.76 x 10-6 M. [I]
0
: (1) 2.00 x 10-5 M; (2J 8.00 x 10-5 M; 















































Reduction of PLPP-cyt c
111 
by 
buffer, pH 7.0, = 0.50, T = 
1.40 x 10-5 M. [I] 0 : (1) 1.00 










































complex I in 0.10 M phosphate 
20.0° C, [PLP -cyt cIIIJg = 
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t ( sec) 
Figure 20. First order plots for the reduction of PLP modified cyt c111 b! complex I. 0.10 M 












Rate constants for the reduction of PLP 
cyt cIII by complex I. 0.10 M phosphate 
µ = 0.50 with NaCl, [PLP 1- cyt cIII] 0 = 
[PLP 2-cyt cIII] 0 = 5.80 x 10-6 M, 20.0° 
-1 4 k (sec x 10) obs 






buffer, pH 7.0, 






III III The reduction of PLP 1-cyt c and PLP 2
-cyt c by complex II was 
III also very similar to the reduction of native cyt c by that complex, 
the data are given in Tables 35 and 36. A representative second order 
plot is shown in Figure 21 and the observed second order rate constants 
for the reaction are given in Table 37. The observed rate constant 
I II 7 -1 -1 for the reduction of PLP 1-cyt c by II is 1.12 (±.20) x 10 M sec 
and for the reduction of PLP
2
-cyt cIII by II is 1.04 (±.27) x 10 7 M-l 
-1 sec III The observed rate constant for the reduction of native cyt c 
under similar conditions is 2.40 (±.31) x 10 7 M-l sec- 1 • 
The introduction of pyridoxal phosphate in the ratio of either 1 
III 
or 2 PLP groups per cyt c molecule has only a small effect on the 
rate of the reaction with II. The rate with I is not affected to any 
appreciable extent and the rate with II is decreased by a factor of 
about 0.5. 
113 
Table 35. Reduction of PLP 2-cyt cIII by complex II in 0.10 M phosphate 
buffer, pH 7.0, µ = 0.50 with NaCl, 20.0° C, [PLP2-cyt cIII]
0 = 3.80 X lQ-6 M. [II] 0 : (1) 4.00 x lQ-6 M; (2) 1.00 x 10-5 














































Table 36. Reduction of PLP
1
-cyt cIII by complex II in 0.10 M phosphate 
buffer, pH 7.0, µ = 0.50 with NaCl, 20.0° C, [PLP
1
-cyt cIII]
0 = 9.04 x 10-6 M. [II] 0 : (1) 3.00 x 10-6 M; (2) 1.00 x lQ-5 M; 
(3) 2.00 x lQ-5 M. 
1 2 3 
t(msec) Assa t (msec) Assa t(msec) Assa 
0 .087 0 .087 0 .087 
5 .125 5 .162 4 .197 
10 .138 10 .187 6 .210 
15 .148 15 .202 8 .221 
20 .156 20 .212 10 .229 
25 .160 25 .220 12 .235 
35 .165 35 .229 16 .243 
Af .175 Af .247 Af .250 
Figure 21. 
11 4 
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Second order plots for the reduction of PLP modified 
cyt cIII by complex II. 0.10 M phosphate buffer, pH 7.0, 
µ • O.SO, 20.0° C, [II] 0 a 1.00 x lQ-5 M. 
<>[PLP1-cyt cIII] 0 • 9.04 x 10-6 M; o [PLP2-cyt cIII]
0 
• 
3.80 x 10-6 M. Cr• [cyt cII] and M
0 
and C are the 








Rate constants for the reduction of PLP derivatives of 
cyt cIII by complex II. 0.10 M phosphate buffer, pH 7.0, 




= 9.00 x 
10- 6 M, [PLP2-cyt cIII]o = 3.80 x 10-6 M. 
-1 -1 6 k (M sec x 10-) 
obs 







III Reduction of Nitrotyrosyl Derivatives of Cyt c 
115 
III The reduction of the mononitromonotyrosyl derivative of cyt c 
III 
(MNMT-cyt c ) by complex I is very similar to the reduction of the 
. III native cyt c The data are shown in Table 38 and a representative 
first order plot is shown in Figure 22. The observed first order rate 
constants for the reaction are given in Table 39 and the value fork b 
0 S 
is 2.75 (±0.12) x 10-
3 
sec-l compared with 0.73 x 10- 3 sec-l for native 
III d . ·1 d i cyt c un er simi ar con it ons. This is about a 3.5 fold increase 
in rate as a result of introducing the nitro group on one of the tyrosyl 
residues. The reaction does, however, maintain a zero order dependence 
on the reductant. 
The reduction of MNMT-cyt cIII by complex II is similar to the re-
duction of native cyt cIII by II. The data are given in Table 40. A 
representative psuedo-first order plot for the reaction is shown in 
Figure 23 and rate constants are shown in Table 41. The observed rate 
116 
Table 38. Reduction of mononitromonotyrosyl (MNMT)-cyt c 111 by complex 
I in 0.20 M phosphate buffer, pH 7.0, µ = 0.50, at 20.0° C, 
[MNMT-cyt cIII] 0 ~ 4.30 x 10-6 M. [I] 0 : (1) 1.60 x 10-5 M; 
(2) 7.80 x 10-5 M; (3) 1.50 x 10-4 M. 
Absorbance (550 nm) 
t(sec) 1 2 3 
0 .058 .055 .051 
50 .059 .056 
100 .067 .062 .059 
200 .074 .069 .067 
300 .078 .075 .074 
400 .081 .079 .079 
500 .082 .082 
600 .089 
700 .084 .086 
1000 .091 .086 .087 
Af .098 .096 .097 
Table 39. Observed rate constants for the reduction of MNMT-cyt c 111 
by complex I. 0.20 M phosphate buffer, pH 7.0, µ = 0.50 
with NaCl, 20.0° C, [MNMT-cyt cIII] 0 = 4.3 x 10-6 M. Rate 
constants are obtained assuming 90% purity (see text). 
[I] (M X 10
5 ) k (sec 
-1 
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t (sec) 
Figure 22. First order plot for the reduction of MNMI'-cyt cIII by 
complex I. 0.20 M phosphate buffer, pH 7.0, µ • o.so. 
20.oo C, [MNMT-cyt cIII] 0 • 4.30 x 10-6 M, [1] 0 • 1.50 x 10-4 M. 
117 
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Table 40. Reduction of mononitromonotyrosyl (MNMT)-cyt cIII by complex 
II in 0.20 M phosphate buffer, pH 7.0, µ = 0.50 with NaCl, 
20.0° C, [MNMT-cyt cIII]
0 
= 2.20 x 10-6 M. Absorbance 
changes measured at 416 nm. [II] : (1) 1.00 x 10-5 M; 
(2) 2.00 x 10-5 M. 0 
1 2 
t(msec) 
A416 t(msec) A416 
0 .160 0 .160 
5 .184 4 .198 
10 .198 6 .203 
15 .204 8 .208 
20 .209 10 .210 
Af .214 Af .214 
Table 41. Observed rate constants for the reduction of MNMT-cyt cIII 
by complex II. 0.20 M phosphate buffer, pH 7.0, µ = 0.50 
with NaCl, 20.0° C, [MNMT-cyt cIII]
0 
= 2.2 x 10-6 M. Rate 
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Figure 23. Pseudo first order plot for the reduction of MNMI'-cyt c 111 
by complex II. 0.20 M phosphate buffer, pH 7.0, µ • 0.50, 
20.0° C, [MNMT-cyt clll] 0 • 2.20 x 10-6 M, [II] 0 • 2.00 x 10-5 M. 
120 
( ) 10 7 M-1 -1 constant is 1.23 ±0.05 x sec compared with 2.40 (±0.31) 
x 10
7 
M-l sec-l for native cyt cIII under similar conditions. The same 
III mechanism obtains for the reduction of MNMT-cyt c as for native cyt 
III 
C The introduction of the nitre group on one of the tyrosyl resi-
dues causes only a small decrease in the rate of reaction with II. 
The more highly substituted nitre derivatives of cyt cIII could 
not be purified on ion exchange columns to give a kinetically homo-
geneous species. Fraction II which was eluted just ahead of MNMT-cyt 
III 
c was rechromatographed once and two fractions isolated. The major 
component in both fractions reacted much more slowly with II than MNMT-
III cyt C The observed rate constant for the reaction of this species 
is 4 -1 -1 1.42 (±0.62) x 10 M sec . The major component in this fraction 
. III III is presumed to be mononitrodityrosyl-cyt c (MNDT-cyt c ) since it 
possesses the same spectral and chromatographic properties as the MNDT-
cyt c described by Pal et al. (121). The major contaminant in both 
fractions reacted very rapidly with II and is presumed to be MNMT-cyt 
III 
C 
The rate of reduction of this fraction with I is not significantly 
III different from the rate of reduction of MNMT-cyt c The observed 
-3 -1 first order rate constant is 2.3 (±0.4) x 10 sec . Again this re-
III action is somewhat faster than the reduction of native cyt c by I. 
III Reduction of Formyl-Cyt c by Complex I 
III 
The reduction of formyl-cyt c by complex I is biphasic. The 
absorbance data are given in Table 42 and a typical first order plot is 





















Reduction of formyl-cyt 
phate buffer, pH 7.5, µ 
cIII] = 2.40 x 10-5 M. 
x lQ-4 M. 
121 
cIII by complex I in 0.40 M phos-
= 1.01, T = 20.0° C, [formyl-cyt 
(1] 0 : (1) 8.00 x lQ-5 M; (2) 5.00 




















from the linear portion of the first order plot beyond the point of in-
flection (i.e. near the end of the reaction). The rate constant for 
the fast phase of the reaction was determined by the Guggenheim method, 
as described in the experimental section. The values of the rate con-
stants for the fast and slow phases of the reaction are given in Table 43. 
The observed rate constant for the slow phase is 2.6 (±0.6) x 10- 4 sec-l 
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Figure 24. First order plot for the reduction of formyl-cyt c 111 
by complex I. Conditions are as described in Table 42 
with [1]
0 





(M x 10 4 ) 
0.80 
5.00 
Rate constants for the reduction of formyl-cyt 
complex I. 0.40 M phosphate buffer, pH 7.5, µ 
20.0° C, [formyl-cy ·t cIII]
0 
= 2.40 x 10-5. 
k 
fast 
(sec -1 10 3 ) X 
1.59 
1.38 








(sec x 10) 
1. 37 
1.08 
III The reduction of formyl-cyt c by II is a very complex reaction 
which appears to be more than biphasic. The oscilloscope tracings from 
III the stopped flow instrument, for the reduction of formyl-cyt c by 
complex II are shown in Figure 25 and the data tabulated in Table 44. 
Some comments can be made about the reaction, however, which are valu-
able to the understanding of the properties of this modified cytochrome. 
The first characteristic of this reaction is a very fast phase, 
which is complete in the dead time of the stopped flow instrument at 
concentrations of II >5.0 x 10-
5 
M. A second order rate constant was 
estimated for this fast phase at a concentration of II approximately 
equimolar with formyl-cyt cIII• using the half-life method. When both 
III -5 
formyl-cyt c and complex II are about 1.9 x 10 M, the half-life 
of the fast phase is ca. 5 msec. Using the relationship 
k = 1 
where a
0 
is the initial concentration of the fast component and t
112 
is 



































































Figure 25. Oscilloscope tracings for the reduction of formyl-cyt c 111 
by complex II. Experimental conditions were: 0.40 M phos-
phate buffer, pH 7.5, µ = 1.01, 20.0° C, [formyl-cyt cIIIJ
0 
= 1.88 x 10-5 M. [IIJo: (a) 1.90 x 10-5 M; (b) 5.00 x 10-J 
M; (c) 1.00 x 10-4 M; (d) 2.00 x 10-4 M; (e) 5.00 x 10-4 M; 
(f) 1.00 x l0-3 M. 
Table 44. Reduction of formyl-cyt cIII by complex II on 0.40 M phosphate buffer, pH 7.5, µ = 1.01 4 20.0° C, [formyl-cyt cIII]g = 1.88 x 10-5 M. [II]
0
: (1) 1.90 x 10-S M; (3) 1.00 x 10-
M; (4) 2.00 x 10-4 M; (5) .oo x 10-4 M; (6) 1.00 x 10-3 M. 
1 2 3 4 5 6 
t(msec) Assa t(msec) Assa t(msec) Assa t(msec) Assa t(msec) Assa t(msec) Assa 
0 .150 0 .150 0 .155 0 .170 0 .215 0 .270 
10 .220 10 .226 10 .250 5 .258 5 .310 5 .368 
30 .232 30 .245 30 .267 10 .278 10 .340 10 .399 
50 .239 so .255 50 .280 30 .304 30 .378 20 .428 
250 .255 250 .285 70 .288 so .316 50 .395 25 .438 
500 .272 500 .312 100 .292 100 .327 70 .400 50 .455 
1000 .300 .000 .340 200 .305 200 .350 100 .406 100 .473 
1500 .318 1500 .360 400 .335 300 .365 200 .427 150 .485 
2000 .329 2000 .370 600 .350 400 .378 300 .440 200 .495 
2500 .338 2500 .378 800 .362 500 .385 400 .448 300 .502 
3500 .344 1000 .373 700 .398 500 .454 
1200 .380 1000 .404 700 .462 
Af .365 Af .393 Af .405 Af .423 Af .473 Af .518 
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The similarity between this rate and the rate of 
III 
reduction of native cyt c by complex II, under similar conditions, 
suggests there may be some residual native cyt cIII present in this 
fraction. There is, however, no other evidence for the presence of 
· III · h. f · h 1 k f 695 b native cyt c int is raction as judged byte ac o nm a -
sorbance and complete autoxidation in air. The maximum amount of native 
III 
cyt c in this fraction would be ca. 5%, which is much too small to 
account for the approximately 30%, or more, fast reaction. 
A first order plot of this reaction for pseudo-first order con-
ditions is linear for the last 40-50% of the reaction, as shown in 
Figure 26. The second order rate constants for this phase, obtained by 
dividing the observed pseudo-first order rate constants by the concen-
tration of II, are given in Table 45 and were reasonably consistent 
at the higher concentrations of II. The second order rate constant 
does, however, decrease by a factor of 2 over a 10 fold increase in 
concentration of II. The larger rate constants at the lower concentra-
tions crable 45) may be due to Mo(V) monomer produced by the fast phase 
of this reaction. The value of the second order rate constant for this 




Reduction of Cyt c by Mo(V)-Penicillamine Complexes 
The reduction of cyt cIII by the dioxobridged Mo(V)-penicillamine 













First order plots for the reduction of formyl-cyt c1II by complex II, Experimental 
conditions were as described in table 43. • -[II]
0 
= 1.00 x 10-4 M, o-[II]
0 
= 2.00 x 10-4 M, 
4-[II] 0 = 5,00 x 10-4 M, e-[II] 0 = 1.00 x 10-J M, 
Table 45. Rate constants for the slow phase of reduction of formyl-
cyt cIII by complex II. 0.40 M phosphate buffer, 5H 7.5, µ = 1.01, 20.0° C, [formyl-cyt cIII] 0 = 1.88 x 10- M. 
kobs is the observed pseudo-first order rate constant and 








(M X 10 4 ) -1 (sec ) (M-1 -1 -3 sec x 10 ) 
1.00 1.37 13.7 
2.00 2.25 11.2 
5.00 3.19 6.38 
10.0 6.94 6.94 
III 
Penicillamine reduces cyt c much more rapidly than L-cysteine and in 
fact is even faster than the rate with I-pen at equivalent concentra-
tions. III The reduction of cyt c by penicillamine was therefore studied 
III in order to better understand the reduction of cyt c by I-pen; absor-
bance data are given in Table 46. The kinetic data for the reaction of 
III · h · ·11 · d "bl ld l"k cyt c wit penici amine were not as repro uci e as one wou i e. 
The reason probably being that penicillamine, like most commercially 
obtained thiols, is not pure to begin with and is also very unstable to 
air oxidation. The small amount of impurities may cause some very 
unpredictable results. In the most carefully controlled study of this 
reaction, at low concentrations of penicillamine, the observed second 















Reduction of cyt cIII by D,L-penicillamine in 0.10 M 
phosphate buffer, pH 7.0, µ = 0.50, T = 20.0° C, fcyt 
= 1.91 x 10- 5 M; [penicillamine]
0
: (1) 1.50 x 10-5 M; 
(2) 2.00 x 10-5 M; (3) 5.00 x 10-5 M; (4) 1.00 x 10-4 M. 
Absorbance (550 nm) 
1 2 3 4 
.217 .217 .225 .208 
.261 .261 .276 .279 
.295 • 295 .318 .332 
.325 .325 .352 .375 
.350 .350 .380 .409 
.367 .372 .405 .435 
.383 .391 .425 .457 
.406 .421 .458 .485 
.421 .444 .479 .502 
.437 .474 .506 .518 
.443 .491 .518 .522 
.451 .523 .529 .529 
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III I-pen reduced cyt c at a rate comparable to the rate of reduc-
tion by complex I; absorbance data are given in Table 47. The rate of 
the reaction did, however, increase with increasing concentration of 
I-pen, the observed rate constants are given in Table 48. A close 
inspection of the kinetic behavior of this reaction showed that the 
data fit a first order plot very well, with an autocatalytic effect 
very similar to the reaction with I. The increase in rate with in-
creasing concentration of I-pen is probably due to the presence of 
residual free ligand, since the dependence of the rate on concentra-
tion of reductant varied with the I-pen preparation. The autocatalytic 
Table 47. Reduction of cyt c
111 
by the dioxobridged Mo(V)-penicillamine dimer (I-pen). 0.10 M 
phosphate buffer, pH 7.0, µ = 0.50, 20.0° C [cyt cIII]
0 
= 4.05-4.15 x 10-5 M. [I-pen] 0 : (1) 3,00 X l0-5 M; (2) 9.00 X 10-5 M; (3) 1.50 x 10-4 M; (4) 5.00 X 10-4; (5) 7.50 x 10-4 M; 
(6) 1.00 x l0-3 M; (7) 2.00 x 10-3 M; (8) 4.00 x 10-3 M. 
Absorbance (550 nm) t(sec) 1 2 3 4 5 6 7 8 
0 .350 .360 .340 .425 .400 .497 .505 .538 50 .375 .393 .370 .494 .472 .600 . 577 .620 100 .392 .420 .400 .557 .529 .687 .643 .690 200 .425 .472 .462 .665 .634 .824 .763 .815 300 
.925 .860 .918 400 .488 .564 .569 .840 .803 1.003 .940 1.000 500 
1.060 1.010 1.065 600 .545 .645 .660 .967 .923 1.102 1.065 1.120 800 .599 . 718 .740 1.057 1.007 1.152 1.147 1.195 1000 .650 .785 .807 1.116 1.062 1.200 1.202 1200 1.153 
1500 .769 .915 .941 1.180 1.123 1.255 2000 .866 1.004 1.027 
2500 .944 1.055 1.072 
3000 1.005 1.080 1.097 
3500 1.047 1.095 
Af 1.125 1.115 1.120 1.195 1.148 1.195 1.270 1.290 
Table 48. Observed rate constants for the reduction of cyt cIII by 
the dioxobridged Mo(V)-penicillamine complex (I-pen). 
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0.10 M phosphate buffer, pH 7.0, µ = 0.50 with NaCl, 20.0° 
C. [cyt cIII] 0 = 4.05-4.15 x 10-5 M. All runs were made 
with the same recrystallized preparation of Mo(V)-penicil-
























effect would be due to the production of penicillamine in the re-
action. 
Because it is difficult to estimate the amount of 
free penicillamine present in solutions of the I-pen complex, only a 
very rough estimate can be made of the rate constant for the reaction. 
The most reasonable estimate would come from the lowest concentrations 
-4 -1 of I-pen used, which gives a value of k = 4-10 x 10 sec . This 
obs 
value is approximately the same as the observed rate constant for com-
-4 -1 plex I (ca. 7 x 10 sec ). 
The reduction of cyt cIII by the monoxobridged Mo(V)-penicillamine 
complex (II-pen) was not easy to study either. The bridge opening re-
action was much slower than the bridge opening of I to form II. The 
bridge opening also did not go to completion at pH 10 in the presence 
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of either added penicillamine or added cysteine. L-cysteine was found 
to catalyze the ring opening more efficiently than penicillamine (123). 
As mentioned in the experimental section, less than 30% of the total 
III molybdenum was reactive with cyt c The absorbance data for the re-
d · f III b bl 49 uction o cyt c y II-pen are given in Ta e • If it is assumed 
that the active molybdenum is the monoxobridged dimer, an estimated 
rate constant for the reaction is 9 x 10 7 M-l sec- 1 . The rate is 
therefore 3 to 4 times faster than the rate of reduction by complex II. 
It may be,however, that the active molybdenum species is something 
other than the monoxobridged Mo(V)-penicillamine complex. 
sults should therefore be interpreted with much caution. 
These re-
It should be pointed out that the purpose of the kinetic studies 
with the penicillamine complexes was to compare them with the analogous 
cysteine complexes. It is obvious that the penicillamine complexes 
will not lend themselves to as rigorous a kinetic investigation as the 
cysteine complexes; the results, however, do suggest that they behave 
similarly. 
Table 49. Reduction of cyt cIII by the monoxobridged Mo(V)-penicil-
lamine dimer (II-pen) in 0.20 M phosphate buffer, pH 7.0, 
µ = 0.40, T = 20.0° C, [cyt cIII] 0 = 1.95 x 10-5 M. 
[II-pen]
0 
= 6.0 X 10- 6 M [II-pen] 0 = 9.1 X 10-
6 M 
t(msec) A550 t(msec) A550 
0 .185 0 .185 
4 .358 5 .423 
6 .370 10 .462 
8 .380 15 .483 
10 .388 20 .497 
14 .400 25 .500 
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DISCUSSION 
III Reduction of Cyt c by Complex I 
III 
Complex I reduces cyt c slowly, with a rate which is indepen-
dent of the concentration of I over a wide range in concentration. 
Several mechanisms can be proposed which would be in agreement with the 
kinetic data for the reduction of cyt cIII by complex I. The first 
mechanism involves the rapid formation of a preliminary complex between 
III 
cyt c and I (reaction 3) and a subsequent rate controlling electron 
transfer (reaction 4) to give products: 
III k3 III 
cyt c + I cyt c -I 
k_3 
(3) 
III k4 II 
cyt c -I --> cyt c + Mo(V) + Mo(VI) + L (4) 
III k5 II 
cyt c -I+ Mo(V) --> cyt c + Mo(VI) + L + I (5) 
where Lis cysteine. The Mo(V) species produced in reaction (4) by the 
one electron oxidation of I by cyt cIII is proposed to be Moo
2
(0H)L 2-. 
III This reactive monomer then rapidly reduces another cyt c -I complex 
(reaction 5). In the reduction of flavins by II, under similar con-
ditions, Mo(V) monomer was observed (22). No such signal was observed 
in this study; therefore, reaction (5) would have to be much faster 
than (4). 2-The Mo(VI) product is Moo
4 
, since Mo(VI) does not complex 
with cysteine to any appreciable extent at pH >6.0 (18). 
The rate expression obtained from this mechanism is: 
II 





1 + K[I] 
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where K = k 3 /k_ 3 • If K[I]>> 1, this expression simplifies to the experi-





[cyt c ] 
Since the rate is independent of the concentration of I at the lowest 
6 concentration used, the minimum value of K is ca. 10. This indicates 
III 
that the cyt c -I complex would have to be quite strong. 
It should be pointed out that no changes were observed in the 
absorption spectrum of cyt cIII immediately after adding I, no change 
was observed in the polarographic reduction wave of I immediately after 
adding cyt cIII and two chromatographic techniques used to detect bind-
III 
ing of I to cyt c were negative. So, although this mechanism is 
consistent with the kinetic data, the negative results in the binding 
studies leave it open to much criticism. 
A second mechanism involves the rapid formation of a "dead end" 
complex (136) (reaction 6) which does not undergo electron transfer. I 
III 
may also react with cyt c to give products (reaction 7). 
III 
+ I 
k6 III cyt C = cyt c -I 
k_6 
(6) 
cyt III + I 
k7 II 
+ Mo(V) + Mo(VI) + L C --> cyt C (7) 
III k8 II 
cyt c -I+ Mo(V) --> cyt c + Mo(VI) + L (8) 
III k9 II 
cyt c + Mo(V) --> cyt c + Mo(VI) + L (9) 
As in the first mechanism, the Mo(V) monomer produced in reaction (7) 
III must be very reactive and would reduce either the cyt c or cyt 
III 
c -I complex rapidly. 
Assuming reaction (7) is rate limiting, the following expression 
obtains: 




[I] [cyt c ] 
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III Applying the steady state approximation to cyt c gives the observed 
rate law: 
II d[cyt c ] 
dt 
III [cyt c -I] 
Although this mechanism is also in agreement with the kinetic data, it 
III 
requires that cyt c and I form a strong unreactive complex, for which 
there is also no other evidence. 
A third mechanism involves a slow conformational change as the 
rate controlling step (reaction 10) followed by a fast interaction of I 
III III with the active conformer of cyt c (cyt c* ) to give products 
(reaction 11): 
III cyt C III cyt c* 
III kll II 
cyt c* +I---> cyt c + Mo(V) + Mo(VI) + L 
cyt CIII + Mo(V) kl2 :n ---> cyt c + Mo(VI) + L 
III kl3 II 






Reaction (12) in this mechanism is analogous to reactions (5) and (8) 
in the other two mechanisms. The same Mo(V) monomer is proposed and is 
d b i . ld . h . h III expecte to every react ve; it wou react wit eit er cyt c or 
*III ( . 13 ) cyt c reaction • 
. · 1 h . d f III b A simi ar mec anism was propose for the reduction o cyt c y 
Cr(II) ion in aqueous chloride media (101). The rate of reduction of 
cyt cIII becomes independent of the concentration of Cr(II) at high con-
centrations. Yandell et al. (101) proposed a mechanism involving the 
breaking of the methionine-BO sulfur-iron bond as the rate determining 
step and subsequent bridging of the Cr(II) and Fe(III) ions by chloride 
to effect electron transfer. The rate limiting step in that reaction 
-1 
has a first order rate constant of 60 sec , which is much faster than 
III the rate of reduction of cyt c by I. The possibility of a slower 
conformational change cannot, however, be eliminated. 
This mechanism gives a similar rate expression: 
II 
d [cyt c ] = 
dt 
which reduces to the observed experimental rate law, 
II 
d[cyt c ] 
dt k 





. Although there is no evidence for such a slow con-
formational change, there is also no evidence against it. 
Looking at the kinetic data in low ionic strength media, it is 
difficult to explain the rather large increase in observed rate con-
stants with increasing concentration of I in phosphate and HEPES buffers. 
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The increase in rate is, however, far from being large enough to sug-
gest a first order dependence on complex I. 
If mechanism three (reactions 10-13) is to be in effect for the 
III 
reduction of cyt c by I, the ionic strength of the medium would 
have to have a very significant effect on the slow, rate controlling 
conformational change. Salernme et al. (52) have proposed that a 
stabilizing anion is located in the heme crevice in the oxidized form 
of cyt c and is displaced by phenylalanine-82, which swings into the 
heme crevice on binding of cytochrome c reductase. If such an anion 
(a buffer ion or Cl-) has to be displaced for interaction of I with 
III 
cyt c , the ionic strength of the medium should have the same effect 
as observed. This does not necessarily imply that complex I replaces 
the anion, but rather that the rate controlling conformational change 
occurs more slowly in the presence of a higher concentration of anions. 
The increase in rate with increasing concentration of I in phos-
phate and HEPES buffers suggests that complex I may catalyze such a 
conformational change. Such a catalytic effect can be visualized as a 
III weak interaction of complex I with the lysine rich region of cyt c 
in the vicinity of phenylalanine-82 (see Figure 2) resulting in the 
phenylalanine side chain favoring a position nearer the heme crevice, 
due to steric factors, consequently favoring displacement of the 
bound anion in the heme crevice. In the presence of high concentrations 
of anion, as in the case with high ionic strength buffers, the inter-
action of I with lysyl residues would probably be less important, due 
to the competition with the other anions in solution. 
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The evidence accumulated for the reduction of cyt cIII by complex 
I favors the third mechanism (reactions 10-13) involving a rate limiting 
conformational change. Such a slow conformational change would appear 
at first to be unimportant in the very rapid physiological reduction 
III 
of cyt c by cytochrome c reductase. Vanderkooi and Erecinska (137) 
found that the redox potential of cytochrome c is lowered ca. 40 mV 
by the presence of cytochrome c reductase, suggesting a strong binding 
interaction between the two proteins. Since the results of the present 
III study indicate that complex I does not bind to cyt c , any contiguous 
interaction between these two species must be very weak. Therefore, if 
III 
electron transfer to cyt c is contingent on a conformational change 
with certain reducing agents (such as cytochrome c reductase or complex 
) d f 1 . db d b. d. III I an con ormationa isomerism cause y re uctase in ing to cyt c 
is the driving force for electron transfer in vivo, as suggested by 
Salemrne et al. (52), a large difference in binding constants for cyto-
III chrome c reductase and complex I binding to cyt c could account for 
III the large difference in the rate of electron transfer to cyt c from 
h h f f III b l these species. Te mec anism or the reduction o cyt c y comp ex 
I cannot, therefore, be totally disregarded as a model for the in vivo 
reduction by cytochrome c reductase simply because of the large dif-
ference in rates. 
Consideration of the activation parameters observed for the re-
III 
duction of cyt c by I suggests that bond breaking may be taking place 
(due to the large value of ~Ht) in the rate limiting step. Such a 
t 
value for ~H may also arise from a conformational change taking place 
in a large molecule such as cyt c. This would also argue in favor of 
the third mechanism. 
III 
Reduction of Cyt c by Complex II 
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III Complex II reduces cyt c very rapidly and the reaction is first 
order in both reactants over the concentration range studied. A 
mechanism which is in agreement with the kinetic data involves an 
III initial one electron oxidation of II by cyt c (reaction 14) and a 
faster reaction between cyt cIII and the Mo(V) monomer which is produced 
in reaction 14 (reaction 15): 
III kl4 II 
cyt c +II---> cyt c + Mo(V) + Mo(VI) + L (14) 
III kl5 II 
cyt c + Mo(V) ---> cyt c + Mo(VI) + L (15) 
where Lis cysteine and the Mo(V) and Mo(VI) species are those proposed 
in the previous mechanisms for oxidation of I. This mechanism leads 
directly to the observed rate law: 
II 




[II][cyt c ] 
The very fast rate of this reaction restricted the limits of the concen-
tration ranges of the reactants. This made it impossible to study the 
III reaction at 695 nm, since the concentration of cyt c would have to 
be such that the reaction would be essentially complete in the dead time 
of the stopped flow instrument. 
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III 
The reduction of cyt c by a number of nonphysiological reduc-
tants has led to at least two general mechanisms (83,101). One 
mechanism involves a rate limiting heme crevice opening with a first 
-1 
order rate constant of 60 sec , and a subsequent rapid reduction of 
the heme iron. The second mechanism involves an outer sphere electron 
transfer through the exposed heme edge or interaction at the periphery 
of the protein, followed by electron transfer via n-cloud interactions 
of aromatic residues and the porphyrin ring. Reductions proceeding with 
a rate more rapid than the heme crevice opening would presumably follow 
the remote pathway. 
h . f d f III b II Te activation parameters or the re uction o cyt c y are 
in keeping with an outer sphere mechanism (102,103), i.e. small values 
for ~Ht (4.8 kcal/mol) and negative values for ~St (-9 eu). Since II 
III 
reduces cyt c at a rate as fast or faster than the natural reductant, 
-1 
sec pH 7.4, 10° C) (78), a 
similar mechanism would be feasible for the in vivo reduction by cyto-
chrome c reductase. 
III Reduction of Ligand Bound Cyt c by Complex II 
III 
The reduction of cyt c by II in the presence of the heme iron 
binding ligands, azide and cyanide, suggests that II does not react 
III with the ligand bound form of cyt c , but instead reduces free cyt 
III 
c rapidly as the ligand dissociates. Sutin and Yandel (76) studied 
1 h h . f III . h igand binding in cytoc rome c and found t e reaction o cyt c wit 
iron binding ligands was in agreement with a mechanism involving a rate 
limiting heme crevice opening and/or breaking of the methionine-80 
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sulfur-iron bond (see literature review). The first order rate constant 
-1 for this rate limiting step was estimated as 60 sec • The rate con-
stants for dissociation of cyanide, azide and imidazole are 1.3 x 10- 5 , 
-1 
5.2 and 2.4 sec , respectively. 
A mechanism for the reduction of N
3
- and CN-cyt cIII by II, which 
is in agreement with the kinetic data, involves the dissociation re-
action for ligand-cyt cIII complex (reaction 16) and the rapid reduction 
III 
of free cyt c by II (reaction 17): 
III + X 
k16 
X-cyt III cyt C 
k-16 
C (16) 
III + II 
k17 
Products cyt C 
(fastt 
(17) 
where X represents ligand. Although Mo(V) monomer is probably also pro-
d di i 17 i · h III i h . it uce n react on , ts reaction wit cyt c snots own since 
does not enter into the rate expression. If Mo(V) monomer were to re-
III 
act with X-cyt c , the observed rate constant for reduction of X-cyt 
cIII by II would be about twice the rate of dissociation of the ligand-
III 
cyt c complex, assuming Mo(V) monomer reacts more rapidly with X-cyt 
III 
c than its rate of dissociation. The observed rate constants are, 
however, in excellent agreement with the rate constants for ligand dis-
III sociation, which suggests Mo(V) monomer does not react with X-cyt c , 
or reacts with a rate much slower than the rate of ligand dissociation. 
III The rate constants for the reduction of cyt c by II in the presence 
-1 -5 -1 
of azide (kb = 5.4 sec ) and cyanide (kb = 1.6 x 10 sec ) are 
0 S O S 
in excellent agreement with such a mechanism, i.e. the rate limiting 
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III step being dissociation of the ligand-cyt c complex. The experi-
mental rate law is obtained from this mechanism by applying the steady 
t t i ti t [cyt CIII]·. s a e approx ma on o 
II 
d[cyt c ] = 
dt 
III 
k_ 16 [X-cyt c ] 
The reduction of cyt CIII by complex II in the presence of imi-
dazole is much more complicated. At low concentrations first order 
-1 
plots are linear giving a first order rate constant of ca. 2.0 sec , 
which is in good agreement with the rate of dissociation of the Im-
III 
cyt c complex and suggests the above mechanism (reactions 16 and 
17) may be in effect. When the concentration of II is at a 5 to 50 fold 
excess, however, the reaction becomes biphasic and the amount of re-
action which occurs in the fast phase is dependent on the concentra-
tion of II. 
-5 III 
The entire reduction of 2.0 x 10 M Im-cyt c occurs in 
the fast phase when the concentration of II is ca. 1.0 x 10-
3 
M. The 
most plausible explanation for this fast phase is that Mo(V) monomer, 
which is in equilibrium with complex II in solution, is reducing the 
III Im-cyt c complex. The esr data indicate that the amount of Mo(V) 
-3 
monomer in a 10 M solution of II would be sufficient to completely 
-5 III 
reduce ca. 2.0 x 10 M Im-cyt c 
The slow phase of the reduction is nearly independent of the con-
centration of complex II at low concentrations of II (as shown in 
Table 28), but shows a rather strong dependence on the concentration of 
II at the higher concentrations, where the slow phase can still be ob-
served. 
III 
This is probably due to the reduction of Im-cyt c by 
complex II, as was shown in the results, since the second order rate 
constants calculated for such a reaction are reasonably consistent 
(see Table 28). 
A mechanism which is reasonably consistent with the data is: 










> II + Mo(V) + Mo(VI) + L C cyt C (19) 
III k20 II 
Im-cyt c +II---> cyt c + Mo(V) + Mo(VI) + L (20) 
cyt cIII + Mo(V) k21 II ---> cyt c + Mo(VI) + L (21) 
Im-cyt cIII + Mo(V) k22 I ---> cyt CI + Mo(VI) + L (22) 
where Im is free imidazole, Lis cysteine and Mo(V) and Mo(VI) are 
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2-
Mo(V) monomer and Mo0
4 
, the species proposed in the previous mechan-
isms. The only steady state approximation that would be valid in this 
mechanism, over the entire concentration range of II studied, is for 
III 
[cyt c ]. The rate expression obtained, cannot, therefore, be put in 
a form which can be integrated and plotted to obtain rate constants or 
ratios of rate constants. 
A computer method, developed by Moore and coworkers (130,131), 
was used, which developes integrated, time dependent expressions for the 
differential rate laws, which are derived from the chemical mechanism 
(see experimental section). The rate constants for reactions 18-22 
have been estimated (see results), and the values for these rate con-
stants which were used in the computer simulation are given in Table 
50. The initial concentrations of all species are known, with the 
possible exception of Mo(V) monomer. The concentration of Mo(V) 
monomer was calculated using a value of K = 4.0 x 10- 7 M for the 
eq 
equilibrium between complex II and Mo(V) monomer. Supplying the com-
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puter program with the rate constants for each step in the mechanism 
and the initial concentration of each species, simulated concentrations 
for each species are generated as a function of time. The simulated 
concentrations for cyt cII, at given times, were compared with the 
b d t · f . II h d 0 • f o serve concen rations o cyt c at t e correspon ing times or 
several sets of initial conditions. Figures 27-29 illustrate the ob-
served vs. computer simulated concentrations of cyt cII as a function 
of time. It is apparent that the simulated data is in good agreement 
with the observed data, considering the uncertainty in determining the 
rate constants and initial concentrations. 
Upon close inspection of Figures 27-29, one may deduce that the 
initial concentration of Mo(V) monomer used at the two lower concen-
trations of II may have been too large. Since these concentrations 
of Mo(V) monomer were calculated from the equilibrium constant which 
was estimated at the high concentration of II, one may suggest that 
another species may enter into the equilibrium expression for the mono-
mer-dimer relationship. It is reasonably certain that cysteine does 
enter into the equilibrium expression in the absence of imidazole 
(138); however, imidazole was found to have a monomer stabilizing 
effect, suggesting it too enters into the equilibrium expression. 
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Table 50. Rate constants for reactions 18-22 which were used for the 
computer simulation of the reduction of Im-cyt cIII by 
complex II 
k18 
60 M-l -1 k_ 18 = 0.75 
-1 = sec sec 
kl9 1.8 10
7 -1 -1 
k20 1.0 10
4 -1 -1 = X M sec = X M sec 
k21 1.5 10
8 -1 -1 
k22 1.0 10
7 -1 -1 = X M sec = X M sec 
Lowering the initial concentration of monomer in Figures 27 and 28, at 
the two lower concentrations of II, would give a better correlation 
between the observed data and computer simulated data. 
III The data obtained for the reduction of cyt c by complex II in 
the presence of imidazole at pH 10 have some interesting implications. 
The observed second order rate constant for the reaction is 6.2 (±1.1) 
4 -1 -1 
x 10 M sec , which is in close agreement with the observed rate 
constant for the reduction of the high pH form of cyt cIII by complex 
II (k = 7.2 (±0.4) x 10 4 M-l sec- 1 ) (134). This suggests that imidazole 
III does not bind to cyt c at this pH and the reaction taking place is 
the reduction of the high pH form of cyt cIII by II. This is further 
supported by the fact that the reaction occurs in a single phase over 
a very wide range in concentration of II. 
III 
The high pH form of cyt c is proposed to have the E-amino 
group of lysine-79 as the sixth ligand of the heme iron, in place of the 
methionine-BO sulfur (62,63). The equilibrium constant for the con-
formational change involving displacement of the methionine-SO sulfur 






















Figure 27. The experimental vs. computer simulated production of 
cyt ell in the reduction of Im-cyt clll by a low concen-
tration of complex II. Experimental data was taken from 
Table 25, [11] 0 = 2.50 x 10-5 M. The rate constants and 
initial concentrations used for the computer simulated 
data were as described in Table 50 and the text [Im-cyt 
clll] 0 = 1.88 x 10-5 M, [cyt clll] 0 = 2.51 x 10-6 M. 
Experimental data, o computer simulated data. 
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Figure 28. The experimental vs. computer simulated production of 
cyt ell in the reduction of Im-cyt clll by an inter-
mediate concentration of complex II. Experimental data 
was taken from Table 25, (11] 0 = 2.50 x 10-4 M. The rate 
constants and initial concentrations used for the com-
puter simulated data were as described in Table 50 and 
the text, [Im-cyt clll] 0 = 1.88 x 10-5 M, [cyt clll] 0 = 
2.51 x 10-6 M. Experimental data, o computer simulated 
data. 
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Figure 29. The experimental vs. computer simulated production of 
cyt ell in the reduction of Irn-cyt cIII by a high con-
centration of complex II. Experimental data was taken 
from Table 25, [11) 0 = 1.00 x 10-3 M. The rate con-
stants and initial concentrations used for the computer 
simulated data were as described in Table 50 and the 
text, [lm-cyt cIIIJ
0 
= 1.88 x 10-5 M, [cyt cIII] 0 = 




approximately 4 times the value for the binding constant for imidazole 
(obtained at neutral pH) (76). It is therefore reasonable to expect 
III 
the cyt c to be predominantly in the high pH form (lysine-79 bound) 
in the presence of imidazole at pH 10. 
The kinetic behavior at pH 10 implies that Mo(V) monomer does not 
III react with the high pH form of cyt c or reacts much more slowly 
h . h I III tan wit m-cyt c III The redox potential for cyt c at pH 10 is 
+0.12 V (64), which is only slightly lower than the redox potential of 
+0.15 V for Im-cyt cIII found in this study. The lack of activity of 
Mo(V) monomer with the high pH form of cyt cIII is probably not thermo-
dynamic. Although the redox potential of the Mo(VI)/Mo(V) couple is 
not known at pH 10, it must be sufficiently negative, since Mo(V) 
monomer was found to reduce flavin (22). It may be that the rate of 
III reduction of the high pH form of cyt c by Mo(V) monomer is much 
slower than the rate of reduction of Im-cyt cIII by that species or, 
there may be only a pH effect on the rate. Since the concentration of 
Mo(V) monomer in a 1.0 x 10-J M solution of II is estimated to be 2.0 
x 10-
5 
M, the second order rate constant for the reduction of high 
pH cyt cIII by Mo(V) monomer must be less than ca. 5 x 10
5 
M-l sec- 1 , 
which is considerably smaller than the estimated rate constant for the 
reduction of Im-cyt cIII by Mo(V) monomer. 




cyt c by complex II is thermodynamically favorable and the apparent 
lack of activity must be purely kinetic. Since the rate of reduction 
III 
of N3-cyt c was not affected by concentrations of II up to 
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-3 1.0 x 10 M, the second order rate constant for reduction of this 




sec and the rate constant for reduction by Mo(V) monomer less than ca. 
4 -1 -1 
10 M sec , if these reactions occur at all. 
The potentiometric titration of complex II indicates a redox po-
tential of -0.15 V; however, complex II reduces flavin mononucleotide 
(22) for which E' = -0.22 V (135). Complex II does not, however, 
0 
reduce CN-cyt cIII, for which E' = -0.40 V (72), which may be a kinetic 
0 
phenomenon as in the case ~ith N
3
-cyt cIII, but because of the extremely 
III 
slow rate of dissociation of the CN-cyt c complex, is probably 
thermodynamic. 
III 
If the reason for lack of activity with CN-cyt c is 
thermodynamic, that would suggest the value of E' for complex II is 
0 
approximately -0.30 to -0.35 V. 
The kinetic limitations with N
3
-cyt cIII must lie in the structure 
III 
and/or electronic properties of the N
3
-cyt c complex. Ikeda-Saito 
III 
and Iizuka (77) found the azide and imidazole complexes of cyt c are 
purely in the low spin state at room temperature. They did find, how-
ever, from esr data, that the axial and rhombic distortions for the 
azide complex are greater than for the imidazole complex. The greater 
basicity of imidazole, with respect ot azide, is expected to decrease 
the electron density on the iron (as well as decrease electron density 
III 
in the prophyrin ring) which would make the Im-cyt c a better elec-
III 
tron sink than N
3
-cyt c This argument has much to recommend it in 
III 
the difference in the kinetic properties of N
3
- and Im-cyt c • 
Furthermore, this would suggest that the mechanism for electron trans-
fer may very well involve the TI-cloud of the porphyrin ring. 
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It should be pointed out that high concentrations of N-acetyl-
methionine had no effect on the electronic absorption spectrum of cyt 
cIII nor did it affect the kinetics with either I or II. These results 
III suggest NAM does not bind to the heme iron of cyt c 
III Reduction of Pryidoxal Phosphate Modified Cyt c 
Aviram and Schejter (122) showed that 1 or 2 PLP groups are co-
III 
valently bound to cyt c upon modification with PLP and borohydride. 
Enzymatic digestion of the modified cyt c and subsequent purification of 
the peptide fragments showed that 3 regions of the peptide may be modi-
fied. These three regions include the amino acid sequences 1-10, 68-74 
and 83-94. III Since the amino terminal glycine in horse heart cyt c is 
acetylated, only lysine residues are subject to modification in this 
procedure. The peptide sequence 1-10 contains 3 lysine residues at 
positions 5, 7 and 8 and the sequence 83-94 also has 3 lysine residues 
at positions 86, 87 and 88. The peptide sequence 68-74 has 2 lysine 
residues at positions 72 and 73. The exact residues modified were not 
determined, but it is known that all of the lysine residues mentioned 
lie on the periphery of the cytochrome c molecule (3), removed from 
the close proximity of the heme, with lysine residues 5, 7 and 8 and 
86-88 in one region of the molecule and residues 72 and 73 in another 
region (see Figure 2). Although three regions of the molecule may be 
modified, a maximum of 2 PLP groups is probably bound. 
The introduction of either 1 or 2 PLP groups per · cyt c molecule 
had essentially no effect on the kinetic behavior with I and only 
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slightly inhibited the reaction with II. The mechanism for reduction 
of the modified cyt cIII in both cases appears to be the same as for the 
native cyt cIII (vide supra). Since PLP modification does not affect 
the absorption bands of the heme prosthetic group of cyt c, one would 
expect that such modification has little effect on the thermodynamic 
properties of the protein (i.e. redox potential). PLP modification was 
found to have no effect on cytochrome c oxidase activity but does in-
hibit NADH-cytochrome c reductase activity by 75%_ in PLP
1
-cyt cIII and 
90% in PLP
2
-cyt cIII (122). 
The 50% decrease in rate of reduction of cyt cIII by II upon PLP 
modification may be due simply to difference in overall charge on the 
III 
cyt c molecule. Lysine residues 72 and 73 do, however, lie in 
close proximity to the hydrophobic heme crevice and tyrosyl-74, which 
has been suggested to be involved in electron transfer by ~-cloud inter-
action of aromatic groups in the protein (116,139). Since PLP 1-
and 
III 
similar reduction by and both are PLP 2
-cyt c have rates of II ca. 
1/2 the rate observed with native cyt c III it likely that the ' seems 
first modification causes inhibition of the reaction and the second 





-cyt cIII by cytrochrome c reductase indicates that 
each modification shows a progressive inhibition of activity with the 
reductase enzyme. Such contradiction in the results with II and re-
ductase may lie in the fact that the reductase is much larger than II 
and the introduction of the second PLP group at a distance somewhat 
removed from the first modification could affect interaction with 
reductase and have no effect on interaction with II. 
III 
Reduction of Nitrated Cyt c 
Th d · f . l III (MNMT III) ere uction o mononitromonotyrosy -cyt c -cyt c 
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by complex I indicates the modification causes a 3.5 fold increase in 
the rate of reaction; this observation is interesting since all other 
modifications of the protein caused inhibition or no change in the rate 
of reduction by I. The rate of reduction of mononitrodityrosyl-cyt 
III III 
c (MNDT-cyt c ) by I was nearly the same as the rate of the MNMT 
derivative. Structural and functional studies of nitrated cyt c (12i) 
indicated the MNMT derivative is modified at tyrosyl-67 and the MNDT 
derivative has the additional modification at tyrosyl-48. The physico-
chemical characteristics of MNMT-cyt cIII suggest a loosening of the 
heme crevice and weakening of the methionine-BO sulfur-iron bond at 
h . 1 . 1 (. . h . cIII). p ysio ogica pH in comparison wit native cyt MNDT-cyt 
III 
C 
exhibited properties indicative of gross conformational change as 
well as change in the iron coordination sphere. These two nitrated 
derivatives of cyt c also exhibited very different chemical behavior, 
III 
MNMT-cyt c was reduced by ascorbate, had 24% activity with NADH-
cytochrome c reductase and the reduced form was autoxidizable (although 
very slowly) and had ca. 100% activity with cytochrome c oxidase. The 
MNDT derivative, on the other hand, was not reduced by ascorbate, had 
essentially no activity with NADH-cytochrome c reductase and was 
autoxidized very rapidly. 
It is interesting to note that although the two nitrated deriva-
tives exhibit such gross differences in physical and chemical properties, 
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their rate of reduction by I is nearly identical, and significantly 
III 
faster than the rate of reduction of native cyt c by I. The in-
crease in rate with the two nitrated derivatives may be taken as 
evidence in favor of complex formation of I at tyrosyl-67, since 
nitration would cause a decrease in the pK and would make the tyrosyl 
a 
residue a better ligand for molybdenum. The increase in rate may also 
be taken as evidence in favor of a slow conformational change in cyt 
III 
c as the rate controlling step in reduction by I. If, in fact, the 
1 t t f f 1 I III i . f e ec ran rans er rom comp ex to cyt c s contingent on a con or-
mational change in the region of the heme crevice, loosening of the 
heme crevice by nitration of tyrosyl-67 may favor such a conformational 
change and account for the increase in the rate of reduction of MNMT-
III cyt C The additional modification of tyrosyl-48 to form MNDT-cyt 
III c , causes gross conformational changes in the protein, evidenced 
by its physicochemical properties (121), with little effect on its 
kinetic properties with complex I. Such results are not necessarily 
III inconsistent with the proposed mechanism for cyt c reduction by I 
involving a rate limiting conformational change. 
It should also be pointed out that the breaking of the met-80 
sulfur-iron bond exhibits an apparent pK of 9.2 in the native cyt cIII 
III III 
but has an apparent pK of 6.2 in MNMT-cyt c (121) (MNDT-cyt c 
apparently does not have the met-80 sulfur-iron bond at any pH). The 
f d i f 
. III rate o re uct on o native cyt c by I is observed to increase 
rapidly with increasing pH above 7.5 (vide supra). These results were 
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interpreted as due to the conversion of I to II under these conditions; 
it is possible, however, that the increased rate is partially due to 
loosening of the heme crevice under alkaline conditions. It is not 
possible to test such a mechanism where most of the cyt cIII would have 
the met-80 sulfur-iron bond broken (i.e. pH> 9), since the rate of con-
version of I to II under those conditions is relatively rapid. 
III 
The reduction of cyt c by II is, however, inhibited by the nitra-
tion of tyrosyl residues. III The rate of reduction of MNMT-cyt c by II 
is ca. III 1/2 the rate observed with native cyt c Such a small change 
in the rate of this reaction suggests that tyr-67 is not directly in-
volved in the electron transfer (i.e. by TI-cloud interaction) since 
introduction of the nitro group should alter the electron density in 
the TI-electron cloud by a very substantial amount. The slight decrease 
in rate may be due to either weakening of the met-80 sulfur-iron bond 
or merely to ionic interactions (nitration lowers the pK of the tyrosyl 
a 
residue and would thus cause a decrease in the net positive charge of 
the protein). 
Nitration of a second tyrosyl residue (presumably tyr-48), giving 
III 
MNDT-cyt c , results in a very large decrease in the rate of reduction 
by II. The observed rate constant for reduction of MNDT-cyt cIII by II 
is two orders of magnitude slower than the reduction of MNMT-cyt cIII 
Tyrosyl-48 is believed to be hydrogen bonded to one of the propionic 
acid side chains of the porphyrin in native cyt c(3). Nitration of 
this residue is expected to lower its pK by ca. 3 units, thus greatly 
a 
decreasing its hydrogen bonding capabilities at physiological pH. The 
III 
MNDT-cyt c exhibits gross conformational changes in the protein as 
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well as changes in the iron coordination sphere (121); such gross changes 
in the structure of the cyt c molecule obviously have a very signifi-
cant effect on its activity. It is possible that the lack of activity 
f MNDT III · h N DH h d d b . o -cyt c wit A -cytoc rome c re uctase an ascor ate is 
thermodynamic, rather than kinetic, in nature. If this is true, the 
redox potential of MNDT-cyt cIII must be less than -50 mV, since the 
potential of ascorbate (deprotonated) is -12 mV (135). Such a thermo-
dynamic argument lends further support to the conformational change 
mechanism (reactions 10-13) for reduction of cyt cIII by I since the 
lowered redox potential would not necessarily affect the rate of a con-
formational change, but should affect the rate of electron transfer (as 
in the binding mechanisms, reactions 3-9). 
III 
Reduction of Formyl-Cyt c 
h d ff 1 III b h h III Te re uction o ormy -cyt c y I suggests tat tis cyt c 
derivative exists as two species. Both phases of the reaction are 
III first order in formyl-cyt c and zero order in I, suggesting a mechan-
III 
ism similar to that proposed for the reduction of the native cyt c 
The difference in the rate constants between the fast and slow phases of 
the reaction is less than one order of magnitude, indicating the two 
phases are probably due to two independent species. The amount of re-
action occurring in the fast phase is constant and about 40% of the 
overall reaction over a wide range in concentration of I, which further 
III suggests the formyl-cyt c exists as two independent species. If the 
two species are in equilibrium, however, their rate of conversion would 
need to be much slower than the rate of reduction by I. 
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The reduction of formyl-cyt cIII by II is much more complex. 
There is a very rapid initial phase in the reaction which accounts 
for approximately 30% of the overall reaction. Although this phase has 
an estimated rate constant very nearly that for the reduction of native 
III III 
cyt c by II, it is probably not due to residual native cyt c 
since there is no additional evidence for any substantial amount of 
native cyt cIII in this fraction. This phase is probably not due to 
Mo(V) monomer either, since the concentration of Mo(V) monomer is much 
too low at the lowest concentrations of complex II. The amount of re-
action which occurs in the fast phase, as in the case with complex I, 
was reasonably constant and about 30-35% of the overall reaction. 
III The slow phase of the reduction of formyl-cyt c by II does show 
a dependence on the concentration of II, although somewhat less than a 
first order dependence. Under pseudo-first order conditions, the ob-
served first order rate constant increases by a factor of 5 over a 10 
fold increase in the concentration of II (see Table 45). Such behavior 
suggests there may be a rate limiting first order reaction, independent 
of the concentration of II, as well as a second order reaction which is 
dependent on the concentration of II. 
III A possible mechanism involves two independent formyl-cyt c 
III 
species, as suggested for the reduction of formyl-cyt c by I. The 
more reactive component, A, reacts with complex II (reaction 23) pro-
II 
ducing formyl-cyt c and Mo(V) monomer, which would react rapidly with 
III 
another formyl-cyt c • The less reactive component, B, reacts with 
II to produce B' (reaction 25) and Mo(V) monomer, where B' may be a 
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B-II complex or a reduced form of B with a lower extinction coefficient. 
Mo(V) monomer also reacts with B to produce B' (reaction 26). B' is 
II 
then converted to formyl-cyt c by a first order process (reaction 27). 
k23 II 
A+ II--> formyl-cyt c + Mo(V) + Mo(VI) + L 
A+ Mo(V) 
k24 II 
---> formyl-cyt c + Mo(VI) + L 
k25 
B +II---> B' + Mo(V) + Mo(VI) + L 
B + Mo(V) 
k26 
---> B' + Mo(VI) + L 
B' 
k27 






This mechanism, like the mechanism for the reduction of Im-cyt 
III 
c by II, gives a nonintegrable rate expression, since the steady 
state approximation would not be valid over a wide range in concentra-
tion of II. The mechanism was tested using the computer method des-
III cribed for the reduction of Im-cyt c by II; however, the computer 
simulated data did not correlate well with the experimental data. The 
problem arises in the computer method of treating B'. It is not likely 
that B' is a complex between Band II, which undergoes a rate limiting 
electron transfer, since the results for reduction of other forms of 
III 
cyt c by II point up to an outer sphere mechanism. If B' is a form 
II 
of formyl-cyt c with a lower extinction coefficient than the final 
reduced product, there is no way to treat such a species in the computer 
method without knowing the relative extinction coefficients of the two 
species. 
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III Physicochemical studies of formyl-cyt c (116) indicate it is 
significantly different from the native protein in that it has an 
altered iron coordination sphere as well as gross perturbations in the 
protein conformation. The lack of the 695 nm band suggests the methio-
nine-BO sulfur is not coordinated to the iron (116). The absorption 
spectrum does, however, indicate the iron is low spin at neutral pH, by 
the absence of the 620 nm band (typical of high spin cyt cIII), which 
suggests a strong field ligand is coordinated to the iron. Studies to 
date have not indicated what the sixth ligand may be. 
The reduction of formyl cyt cIII by Cr(II) ion at pH 6.5 shows two 
phases (118), one phase dependent on the concentration of Cr(II) ion 
(k = 4 x 10 4 M-l sec- 1 ) and the second phase independent of Cr(II) 
-1 
concentration (k = 5.0 sec ). These results were interpreted to mean 
C (II) d . f ff 1 III h" hi . ·1·b . r re uces an active orm o ormy -cyt c w ic sin equi i rium 
with an inactive form of the cytochrome. A similar -interpretation is 
not in keeping with the results of the reduction by complex II, since 
the rate of the slow phase of the reaction was dependent on the concen-
tration of II. 
Another possible interpretation of these results is that a third 
. i h f 1 III f . h" h t component is present n t e ormy -cyt c raction, w ic may reac 
with II directly, or may be in equilibrium with either the fast or slow 
component. 
III The kinetic results of the reaction between II and formyl-cyt c 
do indicate this derivative is not a homogeneous cytochrome species, 
but rather a mixture. A possible explanation of the complex kinetic 
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b h . i h . f f 1 III d. ( .bl 1 · e avior st e existence o ormy -cyt c imers or possi yo 1-
gomers) which are in equilibrium with the monomer. This would account 
III 
for the relative insolubility of formyl-cyt c and the large amount 
of protein which is strongly bound at the top of ion exchange columns 
during chromatographic purification. One must use considerable caution 
interpreting these results and most of the interpretation is purely 
conjectural until more information can be gathered. 
III 
Reduction of Cyt c by Mo(V)-Penicillamine Complexes 
The reduction of cyt cIII by the dioxobridged penicillamine complex 
is very similar to the reduction by I. The similar rate strongly 
favors the mechanism involving conformational change in the protein as 
the rate controlling step (reactions 10-13). 
Interpretation of the kinetic results with the monoxobridged 
Mo(V)-penicillamine complex is highly speculative at best since it is 
difficult, if not impossible, to assess the nature of the molybdenum 
species present. It is obvious that the active molybdenum species is 
capable of extremely rapid electron transfer. The only conclusions 
which can be drawn at this time are that the active Mo(V) species re-
III 
acts with cyt c even faster than complex II, and would probably re-
act in a similar manner, i.e., by the same mechanism (reactions 14 and 
15). 
Although the behavior of the Mo(V)-penicillamine complexes is much 
more complicated than that of the Mo(V)-cysteine complexes, their 
III interaction with cyt c is very similar. Such results suggest that 
the structure and ligands of the Mo(V) coordination sphere strongly 
affect its kinetic behavior. 
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CONCLUSIONS 
It is obvious from the results presented here, that complex I and 
complex II have very different kinetic properties. The reduction of 
III b 1 1 h d . cyt c y comp ex I is very sow and t e evidence accumulate points 
III to a slow conformational change in the cyt c molecule as the rate 
controlling step. Such a slow conformational change and its dependence 
III 
on the reduction of cyt c have not appeared in the literature and 
suggests that complex I is indeed, an unusual reductant. Complex II, 
h h h d d III ·dl · f th t . on t e ot er an, re uces cyt c very rapi y; in act, era e is 
h f d d . f III b . . 1 t e astest reporte re uction o cyt c ya transition meta 
complex. III The reaction between cyt c and II is also first order in 
both reactants. Brown and coworkers (140,141) have indicated, by theo-
retical calculations of dioxobridged and monoxobridged Mo(V) dimers, 
that the electron density in the Mo-Mo, d -d bond is considerably 
CJ CJ 
higher for dioxobridged Mo(V) dimers, which would produce a less favor-
able overlap with oxidant orbitals. 
The reduction of cyt cIII by complex II appears to occur by an 
outer sphere mechanism. The rapid rate of electron transfer (kb = 
0 S 
7 -1 -1 
2.6 x 10 M sec ), the small value for the enthalpy of activation 
(~Ht= 4.8 kcal/mol) and a negative entropy of activation (~St= 
8 6 ) . k . i h h d · f III b - . eu are in eeping wt ot er re uctions o cyt c y outer 
sphere metal complexes (102,103). Two proposed sites of entry for the 
III electron in outer sphere reductions of cyt c are the exposed heme 
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edge (102) or an aromatic residue at the periphery of the protein mole-
cule (probably tyrosyl-74), with subsequent electron transfer, by TI-
electron cloud interaction, to the heme (142). 
III The results of the studies with ligand bound cyt c have some 
very important implications with respect to electron transfer in sulfite 
oxidase and cytochromes in general. It is obvious that the nature of 
the heme iron ligands has a very pronounced ~£feet on the reactivity of 




and Im-cyt c are quite similar and not greatly different from native 
III 
or alkaline cyt c , the kinetic properties of these species are 
grossly different. The fact that cyt cIII is a kinetically more active 
electron acceptor than the endogenous cyt b of sulfite oxidase may be 
attributed to the difference in the iron ligands. Although such argu-
ments are not new, the results presented in this study provide further 
support of the idea that the nature and symmetry of the iron ligands 
strongly influences the reactivity of the cytochrome molecule. 
III 
The fact that complex II reduces native cyt c much more rapidly 
(>2 orders of magnitude faster) than the other forms of cyt c III 
studied, strongly recommends it as a model for the molybdenum moiety 
in the sulfite oxidase enzyme, since kinetic evidence suggests the 
molybdenum in sulfite oxidase transfers electrons to the endogenous cyt 
f h rapidly to Cyt CIII ( 42 ). · b, and may trans er t em even more Further-
more, kinetic studies with sulfite oxidase indicate one heme group of 
the enzyme is reduced more rapidly than the other (42). Such results 
were interpreted as differences in the heme prosthetic group. 
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The difference in rates of reduction may, in fact, be inherent in the 
nature of the Mo(V) species donating the electrons, since the results 
of this study imply the Mo(V) monomer, present in solutions of complex 
III II, is more reactive with native and Im-cyt c but apparently less 
reactive with alkaline or N
3
-cyt III C 
Most information concerning the structure of the molybdenum site 
in enzymes has been obtained from esr studies. Comparison of the esr 
signals observed in xanthine oxidase and sulfite oxidase with known 
mo ybdenum complexes indicates sulfur is a very likely ligand in the 
enzymes. The results of this study indicate complex II may be a good 
model for the molybdenum center in sulfite oxidase, considering its 
rate of electron transfer to cyt c. One apparent discrepancy, however, 
is the fact that the fully reduced enzyme exhibits an esr signal which 
accounts for approximately 50% of the total molybdenum (41). This 
suggests that either half of the molybdenum is antiferromagnetically 
coupled or that only half of the molybdenum is in the 5+ oxidation 
state. Quantitation of the esr signal for xanthine oxidase has shown 
that only about 37% of the molybdenum is esr detectible (11), suggest-
ing stronger magnetic interactions between metal centers in that enzyme. 
Clearly more work must be done to identify the molybdenum site in 
enzymes. If the molybdenum centers are, in fact, spin coupled, the 
results of the present study lend strong support to complex II as a 
model for the molybdenum moiety in enzymes. 
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III Finally, the mechanism for electron transfer to cyt c from var-
ious reductants appears to vary widely. The results of this study 
indicate that, although complexes I and II are physically quite similar, 
their mechanism of electron transfer to cyt cIII are quite different. 
The overall evaluation of the data accumulated in this study, especially 
III the work with modified forms of cyt c , suggests that electron trans-
III 
fer to cyt c from complex II, and possibly complex I, probably occurs 
through the exposed heme edge. Since the nitration of tyrosyl-67 has 
such a small effect on the reduction of cyt cIII by complex II, it 
may be concluded that this aromatic residue is probably not involved in 
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